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ABSTRACT 
 
The effects of supplementing forms of flaxseed on plasma and longissimus muscle (LM) 
fatty acid (FA) composition, finishing performance, and carcass characteristics were 
evaluated in five studies. In study 1, steers were fed diets with soy oil (SO), ground 
flaxseed (Flaxseed), or urea formaldehyde condensation polymer treated flaxseed 
(UFCP). In study 2, steers were fed diets with SO, linseed oil (LO), or a combination of 
flaxseed and field peas that was extruded (LinPro). Feeding flaxseed products increased 
(P < 0.01) α-linolenic acid (ALA), omega-3 FA, and decreased (P < 0.01) n-6:n-3 in LM 
compared to cattle fed SO. Feeding LinPro increased (P < 0.01) ALA, omega-3 FA, and 
decreased (P < 0.01) n-6:n-3 in LM compared to steers fed SO or LO. In studies 3 and 4, 
steers were fed diets with and without Flaxseed and implanted or not. Implanting 
improved (P ≤ 0.05) DMI, ADG, feed efficiency, HCW, and LM area compared to cattle 
not implanted. In study 4, cattle fed Flaxseed had increased (P < 0.01) ALA and omega-3 
FA, and decreased (P < 0.01) n-6:n-3 in LM compared to cattle fed SO. In study 5, 
heifers were fed diets with 0% or 5% linseed meal, and administered with or without 
exogenous hormones (NHTC). Administering exogenous hormones improved (P ≤ 0.02) 
DMI, ADG, G:F, and HCW compared to NHTC cattle. Omega-3 FA increased in LM 
when cattle were supplemented with flaxseed products. Cattle fed LinPro achieved the 
highest levels of ALA and omega-3 FA. Flaxseed products did not interact with implants 
as a natural growth promoter in finishing cattle. 
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Flaxseed 
Flaxseed (Linum usitatissiumum), also known as linseed, is grown throughout the 
Northern United States and Canada. The small, dark oilseeds are processed to release the 
oil from the inner seed. Cold press extraction uses only mechanical pressure to extract the 
oils, leaving approximately 8% oil residues in the remaining solids. Prepress solvent 
extraction uses mechanical pressure and solvents to more effectively remove the oil, with 
as much as 1.5% oil left in the residues. The resulting flaxseed oil contains elevated 
levels of α-linolenic acid (αLA) and may be utilized as a feedstuff rich in energy. The 
residual solids after oil extraction are called linseed meal. The protein of flaxseed is 
concentrated into the linseed meal, making it a good source of protein in livestock diets. 
Depending on the oil extraction method and if solvent soaps are discarded into the solids, 
linseed meal may contain nearly 0 to 8% oil. The remaining seed coat in linseed meal 
contains lignan, a kind of phytoestrogen capable of manipulating estrogenic biological 
activities. The entire seed may also be ground and referred to as ground flaxseed. Ground 
flaxseed contains both αLA and lignan, and provides protein and energy as a feedstuff. 
Flaxseed also can be extruded, a process where heat and pressure are applied as the seeds 
pass through a die. Extruded flaxseed contains both αLA and lignan. The heat applied 
protects the protein from ruminal degradation, providing bypass protein for livestock 
diets. Overall, flaxseed in its many forms may be a good source of energy and protein in 
livestock diets. 
The Phytoestrogen Lignan 
Lignan is a class of phytoestrogen found in plants. Members include lariciresinol, 
isolariciresinol, matairseinol and secoisolariciresinol (SECO). These lignans possess a 
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2,3-dibenzylbutane skeleton, distinguishing them from other phytoestrogens. The hull 
found of flaxseed contains approximately 28 to 369 mg/100 g (Raffaelii et al, 2002) of 
the lignan precursor secoisolariciresinol diglucoside (SDG), which is lacking in 
estrogenic activity.  
Metabolism of Secoisolariciresinol Diglucoside 
The metabolism of SDG produces the metabolites enterodiol (ED) and enterolactone 
(EL). These metabolites are formed by mammalian gut microbes, and therefore are 
coined as mammalian lignans or enterolignans. The metabolic process of forming ED and 
EL begins with SECO. The conversion of SDG releases SECO and initiates the 
metabolism of enterolignans. In a study by Thompson et al. (1991), lignan production 
from flaxseed SDG was shown to generate the highest concentration of enterolignans 
when compared to 67 other food products.  
The metabolism of SDG has been studied primarily in humans and mice. The site 
of conversion and the complex interactions between several bacterial strains has been 
established through in vitro and in vivo experiments. The in vitro findings from Wang et 
al. (2000) helped identify the conversion pathway of SDG shown in Figure 1.   
First, two glucoses are removed from SDG to form SECO. Strains of Bacteroides 
distasonis, B. fragilis, B. ovatus, Clostridium cocleatum and C. ramosum have the ability 
to perform this deglycosylation steps (Clavel et al, 2006). Next, a methyl group is 
removed, yielding demethylated metabolite 22. Bacterial strains Butyribacterium 
methylotrophicum, Eubacterium callanderi, E. limosum and Peptostreptococcus 
productus are capable of this demethylation (Clavel et al., 2006). From metabolite 22, the 
pathway diverges to two different paths, but both result in formation of the same end 
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product. Following the left pathway, the demethylated metabolites 22 and 24 appear 
within 20 to 30 h after SDG incubation (Wang, 2000). Taking the right pathway, the 
dehydroxylated metabolites 23 and 25 materialize after 48 h (Wang, 2000). The timeline 
established by metabolite appearance suggests demethylation occurs first. After diverting 
to the left, metabolite 22 is demethylated a second time to form metabolite 24. Following 
demethylation, metabolite 24 is dehydrolyzed by Eubacterium sp. strain SDG-2 to form 
metabolite 25. Metabolite 25 is again dehydrolyzed by Eubacterium sp. strain SDG-2 to 
yield ED. Finally ED is dehydrogenated to form EL (Clavel et al., 2006).   
These metabolic steps have not been confirmed in ruminants. A metabolism study 
with fistulated goats has revealed SDG metabolism does occur in the rumen, though the 
steps are unknown (Zhou et al., 2009). After administering SDG via jugular catheter at 1 
mg/kg of BW, ED and EL appeared in both rumen fluid and serum. This suggests 
ruminal microbes can metabolize SDG into enterolignans that can be absorbed into the 
bloodstream. Supplementation of SDG affected ruminal metabolism, increasing microbal 
CP concentration and total VFA concentrations, while decreasing ruminal pH and 
ammonia–nitrogen concentration. Microbial profile of the rumen also was affected by 
SDG supplementation. These results demonstrate that SDG supplementation influences 
ruminal bacterial composition and the metabolism of carbohydrates and nitrogenous 
compounds in goats. Previous research has demonstrated that feeding flaxseed can lead to 
formation of ED and EL.  Thangavelu et al. (2008) observed dairy cows supplemented 
with whole flaxseed to have increased fecal concentrations of SDG and ED than those 
supplemented with saturated fatty acids or sunflower seeds. Petit and Gagnon (2009) fed 
various concentrations of linseed meal (0, 50, 100 or 150 g/kg of diet DM) to lactating 
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dairy cows. Milk concentrations of EL increased (P < 0.05) linearly with increasing 
concentrations of linseed meal compared to cows fed control diets. The enterolignan ED 
was not detectable in milk, suggesting ED was completely dehydrogenated to form EL, 
that it was not absorbed, or that it was metabolized post-absorptively. Petit et al. (2009) 
fed 0 or 20% flax hulls to ruminally-fistulated Holstein cows. Fistulated cows fed flax 
hulls had increased (P < 0.05) concentrations of EL in ruminal fluid and milk compared 
to control cows, implying that SDG of flax hulls is metabolized by ruminal microbes and 
transferred into the bloodstream. The works of Thangavelu et al. (2008), Petit and 
Gagnon (2009), and Petit et al. (2009) demonstrate the SDG in flaxseed, fed as the whole 
seed, linseed meal, or as flax hulls, is metabolized in the rumen and absorbed into the 
bloodstream. 
Estrogenic Properties of Enterolignans 
The metabolites ED and EL can exert estrogenic effects, interacting with ligands 
that bind estradiol. These ligands include estrogen receptors (ER) and proteins that 
modulate availability of estrogen to estrogen-dependent tissues. The mammalian lignans 
ED and EL may be either agonistic or antagonistic (Kuiper et al., 1998), and the 
estrogenic effect conferred is influenced by several factors, including phytoestrogen 
potency, binding affinity to ER, and the type of ER. Compared to other phytoestrogens, 
EL may appear to be ineffectual with low potency and weak ER binding (Mueller et al., 
2004). Though ED and EL are relatively weak phytoestrogens, studies have shown their 
interaction with estrogen-binding compounds may lead to significant outcomes.  
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Effects of Enterolignan Binding to Estrogen Receptors (ER) 
The binding of an ER ligand activates ER, causing a genomic reaction that 
upregulates or downregulates specific genes of mRNA. Proteins are produced from the 
translated mRNA to function in hormone-dependent tissues regulating cell proliferation, 
differentiation, and homeostasis (Offermans and Rosenthal, 2008). The sub-type of ER 
affected, whether ERα or ERβ, and the tissues containing the ER dictate the actions that 
follow.  
The enterolignan EL has been shown to bind more strongly to ERα than to ERβ 
(Mueller et al., 2004), suggesting EL is more likely to affect tissues containing primarily 
ERα. The distribution of ER sub-types has been determined in bovine gastrointestinal 
compartments (Pfaffl et al., 2003), various organs and skeletal muscles (Pfaffl et al., 
2001), identifying ERα as the predominant sub-type in the jejunum, whereas ERβ is more 
prevalent in the liver, rumen, and skeletal muscles. These results suggest EL may exert 
stronger effects on jejunum gene expression and function than compared to the ruminant 
stomach or skeletal muscles. To explore this, O’Neil et al. (2009) used ovariectomized 
ewes fed 12.5% linseed meal for 0, 1, 7, or 14 d and implanted with estradiol-17β (E2) for 
0, 6, or 24 h before collecting the jejunum for analysis of jejunal mucosa and mRNA 
expression. Estradiol-17β increased jejunum mass, whereas linseed meal interacted with 
E2 to decrease jejunal cellular proliferation and influence jejunal gene expression. The 
authors speculated the enterolignans from the metabolism of linseed meal caused this 
interaction, affecting ERα activity. O’Neil et al. (2009) suggested further investigation as 
to how this interaction may affect nutrient absorption in females exposed to estrogen.  
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Though EL binds more strongly to ERα than ERβ, EL has been shown to interact 
with ERβ of rat skeletal muscle (Zhou, et al. 2009). Feeding flaxseed lignans (50 ppm) 
with another phytoestrogen, daidzein at 5 ppm, upgraded ERβ expression in soleus 
muscle and the hypothalamus, increased the growth of the femoral muscle, and increased 
serum testosterone levels. Zhou et al. (2009) suggested the phytoestrogens may have 
regulated serum testosterone levels by binding to ERβ in the hypothalamus, resulting in 
decreased protein catabolism and increased hypertrophy of skeletal muscle cells. Bovine 
skeletal muscles are comprised primarily of ERβ (Pfaffl et al., 2001). The ERβ from 
bovine skeletal muscle may respond in a manner similar to that of ERβ in rat muscle, 
stimulating the growth of bovine skeletal muscle. Studies have not been completed 
determining if bovine skeletal muscle growth is altered through the effects of flaxseed 
lignans on bovine ERβ.  
Enterolignan Binding to Estrogenic Ligands 
Flax enterolignans have estrogenic properties, allowing them to interfere with 
estrogenic ligands and circulating estradiol. How and with which compounds 
enterolignans interact to exert these effects has been studied using mouse and human 
models. Sex hormone binding globulin (SHBG) is the main plasma sex hormone 
transport protein and bind readily with endogenous estrogens (Rosner, 1990). The lignan 
EL has been shown to increase levels of SHBG (Aldecreutz et al., 1992). By increasing 
SHBG, more estrogen would be bound, thus decreasing the amount of free estrogen 
available to bind to other tissues. The lignan EL also prevents binding of estrogenically 
steroid binding protein (SBP), thus allowing estrogen to circulate (Benassayag et al., 
1994). The SBP could also bind with EL and transport it into cells, where EL could 
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interfere with estrogen-dependent processes through competitive binding at receptor sites 
(Benassayag et al., 1994). Yet another ligan, α-fetoprotein (AFP), is inhibited by 
enterolignans. The protein AFP modulates activity of estrogens and regulates growth of 
estrogen-sensitive cells (Jacobson et al., 1990). Enterolignans have been shown to 
interfere with this binding (Garreau et al., 1991), affecting AFP-related tumor growth. 
These works demonstrate that enterolignans affect estrogenic ligands SHBG, SBP, and 
AFP, thereby influencing available estrogen and its ability to affect target tissues.  
Antioxidant Effects 
Enterolignans also may be classified as antioxidants due to their capacity for free 
radical scavenging. Vitamin E supplemented in diets is an antioxidant well known for 
increasing shelf life in meat products (Faustman et al., 1989 and Arnold et al., 1993), but 
the lignan of flaxseed actually has antioxidant power 5-fold greater than that of vitamin E 
(Prasad, 2000). The strong antioxidant property of flaxseed may increase shelf life similar 
to supplemented vitamin E. However, research has shown shelf life is improved in steaks 
from cattle fed flaxseed when fed vitamin E compared to steaks from cattle fed flaxseed 
without vitamin E (Good et al., 2004; LaBrune et al., 2008). This suggests the antioxidant 
properties of flaxseed do not improve shelf life as well as vitamin E.  
α- linolenic Acid 
 The inside of flaxseed contains the oil fraction, of which over 50% may contain 
high levels of the omega-3 αLA. This essential long chain FA (LCFA) is a precursor for 
the production of eicosapentaenoic acid (EPA), a precursor to the production of 
docosahexaenoic acid (DPA). Health benefits are associated with diets containing αLA, 
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including proper eye and brain development (Greiner et al., 1997) and decreased 
inflammatory responses (Alexander, 1998). Another essential LCFA is linoleic acid 
(LA), a precursor for arachidonic acid (AA) known to produce pro-inflammatory agents 
(Blok et al., 1996).  
n:6 to n:3 Ratio 
 Western diets often contain higher amounts of n-6 FA, creating a ratio of n-6:n-3 
ranging from 10:1 to 25:1 (Simopoulos, 2000). This elevated ratio may be unhealthy, as 
the recommended n-6:n-3 intake is between 5:1 to 10:1 (WHO and FAO, 1995). 
Therefore it would benefit citizens to consume foods with lower n-6 FA content and/or 
greater n-3 FA content. In the United States, the average fish intake per capita is only 
4.58 g/d (EPA, 2002). However, Americans eat more beef (81.6 g/d per capita; USDA). 
Consequently, n-3 enriched beef could be useful as an alternative source of desirable FA 
in Western diets. Tissue FA composition can be altered by the diet fed to the animal 
(Alexander, 1998). Therefore, it may be possible to feed diets with greater αLA than LA 
as a means of producing salable meat with more desirable fatty FA composition. Flaxseed 
has very low n-6:n-3 of 0.3:1 due to high αLA content (Morris, 2003). Thus, feeding 
flaxseed products may enrich beef products with αLA and help increase n-3 dietary 
intake in Western diets, restoring a more proper balanced n-6:n-3.  
Biohydrogenation of α-linolenic Acid 
 Feeding αLA to cattle will not ensure its enrichment in beef products. The 
ruminant stomach often alters the composition of diet through biohydrogenation, a 
process whereby microbes saturate unsaturated fatty acids (USFA), yielding saturated 
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fatty acids (SFA). Biohydrogenation limits the amount of USFA leaving the rumen. The 
chemical structure of αLA, like that found in flaxseed, undergoes extensive 
biohydrogenation, with only 7.9% bypassing the rumen on average (Scollan et al., 2001). 
The hull of flaxseed offers little protection from biohydrogenation. Biohydrogenation 
proceeds by disrupting the structure of the FA. The FA enters the rumen as part of a 
triacylglyceride, a glycerol molecule connected with ester bonds to three FA. Lipolysis 
breaks the ester bonds, freeing FA from the glycerol. But when high concentrate diets are 
fed ruminal pH is lowered, affecting pH-dependent lypolysis and therefore allowing some 
polyunsaturated FA (PUFA) to bypass the rumen (Harfoot and Hazelwood, 1998). 
Nevertheless, biohydrogenation is a significant challenge to enriching beef, making it 
difficult for n-3 FA to pass through the rumen intact. Some form of protection from 
biohydrogenation is necessary to increase intact n-3 FA for tissue enrichment.  
Tissue Deposition of α-linolenic Acid 
Intact PUFA are deposited into tissue through several steps. First, PUFA is 
esterified into triacylglycerides (TAG) and phospholipids (PL). Then TAG and PL are 
assimilated into chylomicrons and very low density lipoproteins (VLDL) to be carried 
into the lymph and blood. Finally, lipoproteins transport FA to the adipose and muscle 
tissues for deposition into the membrane phospholipids (Demeyer and Doreau, 1999).  
 Diets have been shown to alter tissue FA composition across several species.    
Unlike ruminants, monogastric digestive systems have limited abilities to cause 
biohydrogenation, so it is easier to keep PUFA intact for tissue deposition. When fed 10 
to 20% ground flaxseed, chickens were able to produce omega-3 enriched eggs without a 
discernable difference in taste (Scheideler et al., 1997). Feeding flaxseed has also 
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increased omega-3 content in pork products (Warnants et al., 2001 and Matthews et al., 
2000). Though when fed at 3% of the diet for 65-d, concentrations of thiobarbituric acid 
reactive substrates were increased, indicating a greater propensity for oxidation, though 
levels were unlikely to be detectable by consumers (Riley et al., 2000).  
Increasing omega-3 content of ruminant tissues is more challenging due to 
ruminal biohydrogenation of αLA. Despite the extensive biohydrogenation, changes in 
FA composition and increases in omega-3 content of adipose tissue (Casutt et al., 2000 
and Aharoni et al., 2004) and lean tissue (La Brune et al., 2008 and Maddock et al., 2006) 
have been reported. LaBrune et al. (2008) supplemented ground flaxseed in finishing 
diets, resulting in increased (P < 0.05) plasma and muscle αLA in cattle fed flaxseed 
compared to control cattle. Maddock et al. (2006) supplemented flaxseed, whole, rolled 
and ground, and found all forms of flaxseed supplementation to increase (P < 0.05) 
muscle αLA content compared to control cattle. Kronberg et al. (2006) reported similar 
findings with ground flaxseed supplementation increasing muscle αLA in supplemented 
cattle compared to control cattle, regardless of breed. Extruded flaxseed supplementation 
also has been shown to increase muscle αLA in supplemented cattle in several studies 
(Dawson et al., 2010; Barton et al., 2007; and Raes et al., 2004). An increase in the n-3 
FA αLA is often followed by an increase in total omega-3 content. When supplemented 
with ground flaxseed (Maddock et al., 2006; Kronberg et al., 2006) or extruded flaxseed 
(Dawson et al., 2010; Barton et al., 2007; and Raes et al., 2004) supplemented cattle had 
increased muscle omega-3 compared to control animals.  
A few studies have shown a decrease in muscle n-6 FA when cattle were 
supplemented with whole, rolled, ground or extruded flaxseed (Maddock et al., 2006; 
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Raes et al., 2004). Most studies show muscle omega-6 to not be affected by flaxseed 
supplementation (Dawson et al., 2010; Barton et al., 2007; Kronberg et al., 2006). The 
results of Brenner (1989) imply that metabolism of n-3 FA is preferred over n-6 FA. 
Therefore in the presence of n-3 FA, n-6 FA would not be used as a substrate and 
maintain levels of n-6 FA. Perhaps the results of Benner (1989) explain why some studies 
do or don’t have decreased n-6 FA following flaxseed supplementation.  
Overall, changes in n-6 FA and n-3 FA alter the n-6:n-3 ratio. Previous studies 
consistently demonstrate a decreased muscle n-6:n-3 in cattle supplemented with flaxseed 
(whole, rolled, ground, or extruded) compared to control cattle (Dawson et al., 2010; 
Barton et al., 2007; Maddock et al., 2006 and Kronberg et al., 2006). The ratio changes 
are due to the consistent increase in omega-3, followed by the occasional decrease in 
omega-6.  
The amount of saturated FA can be an indicator to the degree of ruminal 
biohydrogenation. Previous research with whole, rolled, and ground flaxseed (Maddock 
et al., 2006; Kronberg et al., 2006) or extruded flaxseed (Dawson et al., 2010; Barton et 
al., 2007; and Raes et al., 2004) has not affected the amount of monounsaturated FA 
(MUFA) or saturated FA (SFA) deposited in muscle tissues compared to control cattle. 
Thus, ruminal biohydrogenation does not appear to be affected by flaxseed 
supplementation. 
Generally previous research (Barton et al., 2007; Maddock et al., 2006; Raes et 
al., 2004; Scollan et al., 2001) has shown extruded flaxseed supplementation to not affect 
polyunsaturated FA (PUFA) deposition in muscle. In contrast, Kronberg et al. (2006) 
showed extruded flaxseed supplementation to increase PUFA muscle compared to control 
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animals. Yet a diet effect on muscle PUFA is generally not expected since concentrations 
of muscle PUFA are primarily impacted by genetics and are only minorly influenced by 
nutrition (De Smet et al., 2003).  
Flaxseed supplementation, whether fed whole, rolled, ground, or extruded, shifts 
FA deposition in muscle to create a more desirable beef product with elevated levels of n-
3 FA and a more properly balanced n-6:n-3. The seed coat or heat from extrusion may 
provide partial protection against biohydrogenation, allowing for some FA deposition 
into the muscle tissues. Even greater protection from biohydrogenation would be 
warranted so muscle could be further enriched with n-3 FA from flaxseed 
supplementation.  
Effects of Flaxseed on Feedlot Performance 
Generally feeding flaxseed has not affected finishing performance in previous 
research. Maddock et al. (2006) and LaBrune et al. (2008) recorded no effect of ground 
flaxseed fed at 8% and 10%, respectively, on DMI. In contrast, Drouillard et al. (2004) 
reported ground flaxseed supplementation at 5% to increase (P < 0.05) DMI. So long as 
flaxseed doesn’t influence the diet to exceed fat levels greater than 7%, ground flaxseed 
doesn’t appear to impair DMI. Studies feeding ground flaxseed at 5% diet DM 
(Drouillard et al., 2004) and 10% diet DM (LaBrune et al., 2008) have also recorded no 
effect of flaxseed inclusion on ADG or G:F. However, flaxseed at an intermediate level 
of 8% diet DM has been shown to increase ADG and G:F (Maddock et al., 2006), but 
likely resulted from increased energy density in the flaxseed diet. The form of flaxseed 
doesn’t appear to affect performance either. Dawson et al. (2010), Barton et al. (2007), 
and Raes et al. (2004) demonstrated extruded flaxseed does not affect performance. To 
14 
our knowledge LSM has not been evaluated for its affects on finishing performance. 
Flaxseed supplementation in many forms does not impair finishing performance.  
Effect of Flaxseed on Carcass Characteristics 
Previous studies have shown many carcass characteristics, such as yield grade, 
LM area, 12
th
 rib fat thickness, incidence of liver abcesses, and KPH, are not affected by 
feeding flaxseed products (Dawson et al., 2010; Barton et al., 2007; LaBrune et al., 2008; 
Maddock et al., 2006; Raes et al., 2004).  
On the other hand, some studies have shown HCW) marbling scores, and quality 
grade to be affected by flaxseed supplementation. Most report flaxseed supplementation 
to have no affect on HCW (Dawson et al., 2010; Barton et al., 2007; LaBrune et al., 
2008; Raes et al., 2004), yet Maddock et al. (2006) had steers fed flaxseed report heavier 
(P < 0.05) HCW. Supplemented steers may have had heavier HCW as a result of the 
elevated energy from their diets compared to control cattle.   
Previous research shows no effect of extruded flaxseed supplementation on 
marbling scores (Dawson et al., 2010; Barton et al., 2007; Raes et al., 2004). In contrast, 
ground flaxseed has given mixed effects on marbling scores reported in previous research 
(Maddock et al., 2006 and La Brune et al., 2008). Maddock et al. (2006) fed whole, rolled 
and ground flaxseed and resulted in increased marbling scores compared to cattle not fed 
flaxseed. Again, the increased energy density of diets fed to cattle supplemented with 
flaxseed may have contributed to the increased marbling scores. LaBrune et al. (2008) 
fed ground flaxseed, tending to decrease marbling scores in supplemented cattle 
compared to control cattle.  
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Work with extruded flaxseed has shown no effect on quality grade (Dawson et al., 
2010; Barton et al., 2007; Raes et al., 2004). LaBrune et al. (2008) fed ground flaxseed 
and also reported no effect of ground flaxseed supplementation on carcasses grading 
Choice or upper Choice compared to control cattle. In contrast, Maddock et al. (2006) 
reported increased carcasses grading upper Choice in cattle supplemented with flaxseed 
compared to control cattle. This increase in upper Choice carcasses followed an increase 
in marbling scores in cattle fed flaxseed. The increased energy density of the flaxseed 
diets may have contributed to the elevated marbling scores, subsequently increasing 
carcasses grading upper Choice. To our knowledge LSM has not been evaluated for its 
affects on carcass characteristics.  
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Figure 1. Metabolic pathway of secoisolariciresiol diglucoside. 
 
SDG conversion pathway provided by Wang et al. (2000) 
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CHAPTER 2: Treatment of flaxseed with urea formaldehyde 
condensation polymer (UFCP): effects on fatty acid profiles of 
plasma and longissimus muscle in finishing Holstein steers. 
ABSTRACT 
Holstein steers (n = 30; initial BW = 499 ± 46 kg) were used in a finishing study 
to evaluate the effects of treating flaxseed with urea-formaldehyde condensation polymer 
(UFCP) on lipid profiles of plasma and LM. Experimental treatments included corn-
based diets containing soy oil (SO), ground flaxseed (Flaxseed), or ground flaxseed 
treated with UFCP (UFCP Flaxseed). Steers were blocked by initial BW and these 
treatments were replicated across 5 individually-fed steers in each block. Residual feed, 
plasma, and BW were determined every 28-d period. Steers were harvested after 89 or 
119 d on feed (heavy and light blocks, respectively). Body weights were recorded prior to 
transport to the abattoir. Following a 48-h chill, full rib primals were collected from one 
side of each carcass. Plasma and LM tissues were analyzed for fatty acid (FA) profiles. 
Finishing performance and carcass characteristics were not affected (P > 0.16) by diet. 
Cattle fed either flaxseed had greater LM α-linolenic acid and total omega-3 FA than LM 
from control cattle (P < 0.05). Application of UFCP to flaxseed did not affect (P > 0.05) 
degree of saturation in either tissue. Supplementing flaxseed, with or without UFCP 
treatment, increases omega-3 FA in beef products without compromising finishing 
performance or carcass quality.  
Key words: beef, fatty acid, finishing, flaxseed, urea formaldehyde condensation polymer 
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Introduction 
Many Americans do not consume the recommended amounts of n-3 FA (Kris-
Etherton et al., 2000). In the U.S., the consumption of fish is relatively low (4.58 g/d per 
capita; EPA, 2002) compared to that of beef (81.6 g/d per capita; USDA ERS 2005). 
Consequently, n-3 enriched beef could be useful as an alternative source of n-3 FA in 
Western diets.  
Previous studies have investigated the use of forage diets to increase n-3 FA in 
beef (Lorenz et al., 2002). Most cattle in the U.S. are finished on grain-based diets, 
yielding beef products with organoleptic properties deemed desirable by U.S. consumers 
(Medeiros et al., 1987), but with relatively low levels of n-3 FA. Previous research has 
investigated feeding strategies using fish oils (Scollan et al., 2001) and vegetable oils 
with high n-3 content (Clinquart et al., 1991) to alter beef FA composition. However, 
these fats often are altered by ruminal microbes through biohydrogenation (BH), limiting 
n-3 FA assimilation and deposition into tissues.  
Flaxseed is rich in the n-3 FA α-linolenic acid (ALA). Feeding flaxseed can 
increase concentrations of n-3 FA in adipose (Casutt et al., 2000) and lean tissues 
(Maddock et al., 2006; La Brune et al., 2008), suggesting some FA escape 
biohydrogenation. Protection of these FA against ruminal BH could increase FA that are 
available for tissue deposition.  
Urea-formaldehyde condensation polymer (UFCP) has been effective as a method 
to decrease susceptibility of plant protein meals to microbial degradation (Lebo and 
Winowiski, 2008). Briefly, UFCP is combined with plant proteins and water, and then 
heated to induce covalent bonding of UFCP to proteins. Conceivably, this same 
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technology could be applied to oilseeds, thus encapsulating lipids with ruminally 
undegraded protein to inhibit microbial BH. The objective of our study was to evaluate 
UFCP treatment of flaxseed as a method to decrease BH of lipids, thereby increasing the 
proportion of n-3 FA available for deposition into meat.  
Materials and Methods 
This study was conducted in accordance with procedures approved by the Kansas 
State University Institutional Animal Care and Use Committee.  
Animals and Diets 
Experimental treatments included corn-based diets containing soy oil (SO), 
ground flaxseed (Flaxseed), or UFCP Flaxseed. Composition of diets is summarized in 
Table 1. The fatty acid profile of diet ingredients is summarized in Table 2.  
To minimize differences in gastrointestinal tract fill, steers were fed a common 
diet based on dry rolled corn for several days before initiation of the experiment. Cattle (n 
= 30; initial BW = 499 ± 46 kg) were blocked by individual BW into 2 groups (heavy and 
light) and assigned randomly within block to 1 of 3 dietary treatments. Steers were 
housed within barns consisting of 20 individual partially-covered concrete pens per barn 
with each pen measuring 1.5 m × 6 m. On d 1, steers were implanted (Revalor XS; 200 
mg of trenbolone acetate, 40 mg of estradiol; Intervet Inc., Millsboro, DE), dewormed 
(Safeguard; Intervet, Inc., Millsboro, DE), individually weighed and identified with 
uniquely numbered ear tags. Baseline blood samples were collected in heparinized 
vacuum tubes (BD; Franklin Lakes, NJ) via jugular puncture. Tubes were immediately 
placed onto ice before centrifuging at 3200 × g for 10 min to recover plasma. Every 28 d 
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thereafter, cattle were individually weighed, unconsumed feed was weighed, and blood 
samples were collected.  
Feed was offered ad libitum and delivered to individual fenceline feed bunks once 
daily at approximately 1300 h. Feed refusals were recorded every 28 d or as needed when 
excess residual feed accumulated in feed bunks. Water from a municipal supply was 
offered ad libitum using automatic water fountains shared between adjacent pens.  
Harvest Data Collection and Sampling Procedures 
The heavy weight block was harvested on d 89, and the light weight block was 
harvested on d 119. Final BW (gross BW × 0.96) was determined before cattle were 
transported to a commercial abattoir in Holcomb, KS. Incidence and severity of liver 
abscesses and HCW were recorded the d of harvest. Incidence and severity of liver 
abscesses were scored according to the scoring system (Brink et al., 1990): 0 = no 
abscesses; A
−
 = 1 or 2 small abscesses or abscess scars; A
0
 = 2 to 4 small, well-organized 
abscesses; and A
+
 = 1 or more large or active abscesses with or without adhesions. 
Carcass data were collected after a 24-h chill for the heavy block and after a 72-h chill for 
the light block. Boneless ribs from the 6
th
 through the 12
th
 rib section were collected from 
the left side of each carcass. Marbling scores, KPH, 12
th
 rib fat thickness, LM area, 
USDA yield grades, and USDA quality grades were determined. Actual BW × 0.96 was 
used to determine dressing percent.  
Dry matter intakes were calculated from the as-fed deliveries using actual 
feedstuff DM values, less the amount of unconsumed DM. Daily gain was calculated as 
kg of gain on a shrunk basis. Feed efficiency was calculated as kg of gain per kg of dry 
matter consumed.  
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Analyses of Plasma Fatty Acids 
Blood was collected from steers using heparinized tubes (BD, Franklin Lakes, NJ) 
18-h postfeeding on d 1 and at 28-d intervals thereafter, and immediately placed onto ice 
before centrifuging at 3200 × g for 10 min to recover plasma. Plasma was freeze dried 
(500 ul) and combined with 1 mL benzene containing internal standard (1000 ug/mL 
methyl-C:13) and 4 mL BF3-Methanol reagent (Supelco B1252). Tubes were incubated at 
60°C for 60 minutes and then cooled to room temperature. Hexane (1 mL) and H20 (4 
mL) were added and tubes were vortexed. Tubes were then centrifuged at 1000 × g for 5 
min. The organic solvent layer (1 to 2 mL) was then analyzed via gas chromatography 
(Schimadzu model 17A, Palo Alto, CA) equipped with a Supelco SP-2560 capillary 
column (100 m × 0.25 mm × 0.20u film) using He as the carrier gas at a flow rate of 1.1 
mL/min. Initial temperature was 140 C for 4 min, followed by an increase of 4 C/min to a 
final temperature of 240 C. 
Muscle Sample Analyses 
At collection, boneless ribs were placed into multipurpose plastic bags, 
transported to the Kansas State University Meats Laboratory, and refrigerated overnight 
at 0 ± 2°C. Rib sections were weighed and vacuum packaged in Nylon/PE Multivac bags 
(Ultravac Solutions, Kansas City, MO) using a Multivac vacuum packager (Multivac 
C500, Sepp Hagenmüller GnbH & Co, Germany). Vacuum was checked using a 
Kennedy Gauge (Kennedy Gauge, Kennedy Enterprises, Lincoln, NE) with an average 
vacuum reading of 0.7774 Bar. Vacuum packaged ribs were stored for an additional 16 d 
at 0 ± 2 C. Starting at the cranial end of the ribs, a steak (2.54 cm thick) was removed for 
analysis of long-chain fatty acid (LCFA) composition. Longissimus muscle LCFA 
profiles were analyzed following the procedures of Sukhija and Palmquist (1988). 
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Briefly, 50 to 500 mg of samples were mixed with 2 mL internal standard in benzene and 
3 mL methanolic-HCl before being flushed with nitrogen. Tubes were then capped and 
vortexed, heated for 2.25 h at 70 C, and vortexed every 45 min during heating. Tubes 
were cooled to room temperature and mixed with 5 mL 6% K2CO3 and 2 mL benzene 
while being vortexed. Tubes were centrifuged at 500 × g for 5 min. The organic solvent 
layer was then analyzed using a Schimadzu gas chromatography (model 17A; Schimadzu 
Corp., Palo Alto, CA) equipped with a Supelco SP-2560 capillary column (100 m × 0.25 
mm × 0.20 um; Supelco Inc., Bellefonte, PA) using He as the carrier gas at a flow rate of 
1.1 mL/min. Initial temperature was 140 C for 4 min, and was increased by 4 C/min to a 
final temperature of 240 C.  
Statistical Analyses 
Plasma LCFA, muscle LCFA, growth performance, and carcass characteristics 
were analyzed using the MIXED procedure of SAS (version 9.0, SAS Inst. Inc., Cary, 
NC). Animal was the experimental unit, diet was the fixed effect, and animal was the 
random effect for analysis of plasma LCFA, muscle LCFA, growth performance, and 
carcass characteristics. The statistical analysis of plasma LCFA also included diet × day 
and day as fixed effects. USDA quality grade and liver abscesses were calculated and 
analyzed using Monte Carlo’s Chi Square analysis (Higgins, 2004) with animal as the 
experimental unit and block as the random effect. Plasma served as the experimental unit 
for plasma LCFA analyses. Ribs served as the experimental unit for muscle LCFA 
analyses. Mean comparisons were determined following an F-test with P ≤ 0.05. Means 
and differences were considered different at P-value ≤ 0.05, with a P-value of ≤ 0.10 
considered as a tendency.  
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Results and Discussion 
Performance 
Performance results are reported in Table 3. In the present study inclusion of 10% 
flaxseed or 10% UFCP flaxseed did not affect (P > 0.58) performance, consistent with 
results from studies feeding 5% flaxseed (Drouillard et al., 2004) and 10% flaxseed 
(LaBrune et al., 2008).  
Several studies have reported that feeding flaxseed has no effect on DMI, 
(Drouillard et al., 2004; Maddock et al., 2006; LaBrune et al., 2008), yet Good (2004) 
reported a linear effect of 5, 10, and 15% flaxseed inclusion on DMI. Studies feeding 
flaxseed at 5% (Drouillard et al., 2004), 10% (LaBrune et al., 2008), and 5, 10 and 15% 
diet DM (Good, 2004) reported no effect of flaxseed level on ADG or G:F. In contrast, 
Maddock et al. (2006) observed that feeding flaxseed at 8% of diet DM increased ADG 
and G:F.  
Carcass Characteristics 
Results for carcass characteristics are reported in Table 3. The effects of feeding 
flaxseed on carcass quality are inconsistent between previous studies. Good (2004) 
observed a quadratic effect of various levels of flaxseed (0, 5, 10, and 15%) on 12
th
 rib fat 
thickness. Feeding flaxseed also increased KPH and USDA yield grade, agreeing with the 
observations of Maddock et al. (2006). Contrasting Good (2004), Maddock et al. (2006) 
reported increases in HCW, marbling scores, and percentage carcasses grading premium 
Choice when cattle were fed 8% flaxseed.  
Fatty Acid Profiles 
 Plasma and muscle LCFA composition results are reported as absolute values 
(Tables 4 and 6) and percent of total FA (Tables 5 and 7).  
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Previous research which have reported that flaxseed supplementation does not 
affect muscle content of MUFA (Maddock et al., 2006; Kronberg et al., 2006), PUFA 
(Scollan et al., 2001; Raes et al., 2003; Maddock et al., 2006), or SFA (Kronberg et al., 
2006). It was hypothesized UFCP would covalently-bond with lipids, protecting FA 
against ruminal BH. If BH were decreased, unsaturated FA would increase in cattle fed 
UFCP Flaxseed compared to cattle fed Flaxseed. Unsaturated FA were measured across 
several categories including monounsaturated FA (MUFA), polyunsaturated FA (PUFA), 
and the ratio of PUFA relative to saturated FA (PUFA:SFA). Excluding LM percent 
PUFA, plasma and LM unsaturated FA categories were not affected (P > 0.05) in cattle 
fed UFCP Flaxseed compared to cattle fed Flaxseed, suggesting UFCP was not effective 
in protecting flaxseed FA from ruminal BH.  
The high levels of omega-3 in flaxseed have been observed to alter n-3 FA 
composition in plasma and muscle from cattle fed flaxseed (Maddock et al., 2006; 
Kronberg et al., 2006; LaBrune et al., 2008). Flaxseed diets of the current study affected 
n-3 FA composition so that steers fed Flaxseed and UFCP Flaxseed had increased 
absolute and percent values of ALA (P < 0.01), omega-3 (P < 0.01), and decreased n-6:n-
3 (P < 0.01) in plasma and muscle tissues compared to control cattle.  
The changes in plasma n-3 FA occurred quickly. On d 28, cattle fed flaxseed 
products had greater (P > 0.05) plasma omega-3 FA concentration than control cattle, 
maintaining elevated plasma omega-3 throughout the trial. There were no differences (P 
> 0.05) in plasma omega-3 between cattle fed Flaxseed and UFCP Flaxseed. Increases in 
plasma concentrations of omega-3 FA subsequently altered the ratio of n-6 and n-3 FA, 
so that plasma n-6:n-3 generally followed changes in plasma omega-3. Although cattle 
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fed UFCP Flaxseed had different (P < 0.05) d 1 plasma n-6:n-3 than other treatments, 
cattle fed flaxseed products had lower (P < 0.05) n-6:n-3 than control cattle by d 28 and 
maintained these reduced levels throughout the trial. Similarly, Good (2004) reported that 
feeding flaxseed increased the omega-3 ALA in plasma and decreased plasma n-6:n-3 by 
d 30 when compared to control cattle, and maintained these altered levels throughout the 
remainder of the trial. 
Duration of feeding affected plasma LCFA composition (Figure 1 through 6). The 
interaction between diet and day affected (P < 0.01) plasma omega-3. In cattle fed UFCP 
flaxseed, levels of plasma omega-3 were not different on d 28, 56, 84, and 112. In 
contrast, cattle fed Flaxseed had greater (P < 0.01) plasma omega-3 on d 56 and 112 than 
d 28 and 84. Similarly, Drouillard et al. (2004) reported that duration of feeding ground 
flaxseed affected n-3 FA concentrations in edible tissues. There was also an interaction 
between diet and day for plasma n-6:n-3 (P < 0.01); however, for the flaxseed diets, 
levels of plasma n-6:n-3 were not affected (P > 0.05) by days on feed.   
In the current study, plasma collected 5 d prior to harvest had similar LCFA 
composition compared to muscle LCFA composition. Similarly, LaBrune et al. (2008) 
reported plasma collected 14 d prior to harvest to have comparable LCFA composition to 
muscle LCFA composition. Results from flaxseed studies of Good (2004) also suggest 
increases in plasma n-3 FA generally reflect increases in muscle n-3 FA composition. 
Therefore, changes in plasma LCFA over time may indicate the necessary duration of 
feeding required to effectively alter muscle LCFA composition.  
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Results from this study suggest application of UFCP does not affect ruminal BH 
or FA deposition. Feeding flaxseed products, with or without UFCP, can increase omega-
3 FA in beef products without compromising finishing performance or carcass quality.  
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Table 1. Composition of treatment diets reported on a DM basis.
§
 
 Treatments 
Item, % DM Soy Oil Flax UFCP 
Ingredients    
    Dry rolled corn 70.87 68.81 68.69 
    Corn silage 9.99 10.00 10.00 
    Ground flaxseed - 10.00 - 
    UFCP flaxseed - - 10.12 
    Corn steep liquor   3.00   3.00   3.00 
    Molasses 3.00   3.00   3.00 
    Soybean meal 4.05 -  
    Feed additive
b
 1.96 1.96 1.96 
    Limestone 1.67 1.64 1.64 
    Urea, 46% N 1.01 1.01 1.01 
    Salt 0.30 0.30 0.30 
    Vitamin premix 0.22 0.22 0.22 
    Trace mineral premix 0.06 0.06 0.06 
Nutrients, %    
    DM 73.19 74.60 74.65 
    CP 12.67 12.91 13.41 
    P   0.46   0.48   0.48 
    Ca   0.72   0.74   0.74 
    Ether extract   7.61 6.35 7.04 
    NDF 10.43 11.23 11.22 
§
SO = Soy Oil, Flax = Flaxseed, UFCP = Flaxseed treated with urea 
formaldehyde condensation polymer.
 
a
Formulated to provide 0.3% salt, 2650 IU vitamin A, 22 IU vitamin E, 0.10 
mg Co, 10 mg Cu, 0.5 mg I, 0.25 mg Se, 50 mg Mn, and 50 mg Zn per kg diet 
DM.  
b
Provided 300 mg monensin and 90 mg tylosin (Elanco Animal Health; 
Greenfield, IN) in a ground corn carrier. 
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Table 2. Ingredient fatty acid profiles reported on an as-is basis.
§
 
Fatty acid, % of 
sample
¥
 
Ingredient 
Soy Oil Flax UFCP  
No. of sample 3 3 3 
C10:0 0.007 0 0 
C11:0 0.002 0.003 0 
C12:0 0.001 0.006 0.002 
C14:0 0.018 0.005 0.002 
C14:1 0.006 0.005 0 
C15:0 0.009 0.006 0 
C15:1 0.088 0.002 0 
C16:0 4.309 2.006 2.170 
C16:1 0.003 0.005 0.013 
C17:0 0.003 0.001 0.033 
C17:1 0.028 0.004 0.023 
C18:0 1.706 1.462 1.747 
C18:1nt9 0.207 0.012 0.011 
C18:1nc9 7.272 6.782 8.630 
C18:1n7 0.648 0.303 0.333 
CLA c9, t11 0.005 0.003 0.001 
CLA t10, c12 0.004 0 0.001 
C18:2nt6 0.004 0.003 0.001 
C18:2nc6 20.690 5.670 7.379 
C18:3n3 3.059 19.665 20.450 
C18:3n6 0.010 0.093 0.099 
C20:0 0.138 0.069 0.082 
C20:1 0.083 0.039 0.048 
C20:2 0.042 0.001 0.018 
C20:3n6 0.001 0.003 0.008 
C20:4n6 0.033 0.008 0.012 
C20:5n3 0.002 0.009 0.002 
C21:0 0.030 0 0 
C22:0 0.19 0.056 0.055 
C22:5n3 0.006 0 0.004 
C22:6n3 0 0 0.001 
C24:0 0.090 0.040 0.048 
C24:1 0.032 0.012 0.009 
omega-3
a
 3.067 19.674 20.457 
omega-6
b
 20.792 5.780 7.502 
SFA
c
 6.502 3.653 4.139 
MUFA
d
 0.241 0.066 0.094 
PUFA
e
 23.901 25.456 27.977 
§
SO = Soy Oil, Flax = Flaxseed, UFCP = Flaxseed treated with urea formaldehyde condensation 
polymer.
 
¥
Number after C denotes number of Carbons; n denotes the double bond location from the 
omega position; c and t denote the cis or trans configuration.  
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a
omega-3= C18:3n3 + C20:5n3 + C22:5n3 + C22:6n3 
b
omega-6 = C18:2nt6 + C18:2nc6 + CLAc9t11 + CLAt10c12 + C18:3n6 + C20:3n6 + C20:4n6  
c
SFA = C14:0 + C16:0 + C17:0 + C18:0 + C20:0 + C21:0 + C22:0 + C24:0 
d
MUFA = C14:1 + C16:1 + C17:1 + C18:1nt9 + C18:1n11 + C18:1nc9 + C18:1n7 + C20:1 + 
C24:1 
e
PUFA = C18:2n6t + C18:2n6c + CLAc9t11 + CLAt10c12 + C18:3n6 + C18:3n3 + C20:2 + 
C20:3n6 + C20:4n6 + C20:5n3 + C22:5n3 + C22:6n3 
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Table 3. Effect of diet on performance and carcass characteristics.
§
 
  Treatments    
Item Soy Oil Flax UFCP  SEM P-value
₤
 
Initial BW, kg 497.7 497.2 498.8 16.2 0.89 
Final BW
†
, kg 621.2 615.5 612.7 13.7 0.88 
DMI, kg/d 12.58 12.60 12.03 0.56 0.58 
ADG, kg/d 1.16 1.11     1.07 0.11 0.82 
G:F 0.091    0.088           0.088 0.007       0.89 
HCW, kg 391.8 381.9 378.8 8.04 0.48 
LM area, cm
2
 79.6      72.0 79.8 3.22 0.16 
Fat thickness, cm 0.54      0.45 0.50 0.08 0.76 
KPH, % 2.77      2.68           2.73 0.14 0.91 
Liver abcesses, % 0.0 0.0 0.0 - 1.00 
Dressing percent 63.0 62.0 61.9 0.005 0.27 
Average YG 2.63 3.00 2.50 0.16 0.06 
Marbling score
‡
 560 573 498 30 0.15 
Select, % 0.0 0.0   10.0 - 1.00 
Choice, % 75.0 88.9 90.0 - 0.64 
Prime, % 25.0 11.1 0.0 - 0.17 
§
SO = Soy Oil, Flax = Flaxseed, UFCP = Flaxseed treated with urea formaldehyde 
condensation polymer.
 
†
Calculated as full BW × 0.96 
‡
300 to 399 = Slight, 400 to 499 = Small, 500 to 599 = Modest, 600 to 699 = Moderate 
¥
Monte Carlo Exact Fit Chi Square analysis (Higgins, 2004) 
a,b,c
Means within a row without common superscripts are different (P ≤ 0.05) 
₤
Effect of diet
 
P-value
 
protected by an overall F-test ≤ 0.05 
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Table 4. Effect of diet on plasma concentrations of fatty acid profiles reported on an as-is basis.
§
  
Fatty acid, 
mg/L
‡
 
d 0  d 28  d 56  d 84  P-value
₤
 
SO Flax UFCP  SO Flax UFCP  SO Flax UFCP  SO Flax UFCP SEM Diet DOF
†
 D×DOF
¥
 
C12:0 1.73 3.21 2.05  1.31 2.13 1.01  1.80 1.43 1.24  1.22 1.67 1.79 0.62 0.29 0.25 0.74 
C14:0 2.39 1.30 1.40  2.27 1.89 3.42  1.92 3.85 5.03  1.40 2.52 2.10 1.11 0.54 0.12 0.52 
C14:1 2.36 2.54 3.31  2.28 1.63 3.44  2.74 3.34 1.72  1.80 2.36 4.34 0.87 0.32 0.95 0.27 
C16:0 153.6 134.4 130.0  162.7 131.3 136.1  139.4 132.5 116.8  140.0 117.5 118.7 9.4 0.02 0.02 0.80 
C16:1 21.08 20.48 19.55  12.64 19.32 16.43  4.16 13.70 10.20  3.43 2.53 2.53 2.41 0.11 <0.01 0.28 
C17:0 10.03 10.56 8.08  4.71 5.54 4.08  1.98 1.24 5.60  3.07 9.16 6.25 1.89 0.45 <0.01 0.24 
C17:1 5.43 5.89 4.90  3.64 2.68 3.21  3.29 2.45 2.30  3.50 3.64 1.73 0.78 0.21 <0.01 0.75 
C18:0 235.6 218.5 222.2  295.6 242.2 255.3  241.6 240.2 222.7  248.0 195.6 224.2 20.0 0.30 <0.01 0.56 
C18:n1t9 26.28 24.86 29.20  31.49 14.78 20.87  19.36 13.99 12.72  13.94 10.45 12.03 3.59 0.12 <0.01 0.19 
C18:n1c9 96.98 85.01 76.01  86.83 88.89 85.04  84.71 96.35 80.36  68.90 83.59 68.66 6.81 0.22 0.01 0.25 
C18:1n7 12.98 9.79 9.46  13.53 8.97 7.26  9.87 6.96 6.03  4.92 2.68 2.06 1.72 0.04 <0.01 0.94 
CLA c9, t11 3.16
a
 0.95
d
 2.11
abcd
  2.05
abcd
 0.98
d
 1.12
cd
  0.89
d
 2.58
abc
 1.23
cd
  2.25
abcd
 1.86
abcd
 2.73
ab
 0.58 0.62 0.12 0.02 
CLA t10, c12 3.14 1.73 0.78  0.90 1.84 0.55  0.89 0.93 0.46  1.38 0.64 1.54 0.67 0.27 0.21 0.29 
C18:2nt6 4.37 3.58 3.27  4.88 4.93 6.94  1.25 1.46 1.80  1.83 1.78 2.44 1.23 0.70 <0.01 0.92 
C18:2nc6 595.4
abc
 579.9
a
 585.0
ab
  906.1
l
 654.9
abcdef
 717.1
defghij
  745.3
defghijk
 692.7
bcdefgh
 661.0
abcdefg
  703.2
defghi
 604.8
abcd
 624.5
abcde
 57.6 0.27 <0.01 0.03 
C18:3n3 24.00
abcde
 13.77
ab
 11.98
a
  27.97
abcdef
 135.12
gh
 164.18
ghi
  18.67
abcd
 168.73
i
 158.20
ghi
  15.53
abc
 129.54
g
 159.21
ghi
 13.03 <0.01 <0.01 <0.01 
C18:3n6 19.77 21.62 17.20  13.57 11.32 9.92  20.45 10.63 8.45  11.52 8.83 5.79 2.56 0.02 <0.01 0.27 
C20:0 2.76 1.91 1.40  2.54 1.42 2.06  1.73 2.47 3.11  2.56 1.96 1.22 0.70 0.64 0.76 0.34 
C20:1 2.55 2.42 2.01  1.43 1.37 1.14  1.39 1.47 1.96  1.05 2.59 3.08 0.75 0.67 0.27 0.67 
C20:2 7.47 5.47 5.57  2.33 2.41 3.65  2.91 4.17 3.42  3.36 4.32 5.11 0.97 0.84 <0.01 0.35 
C20:3n6 42.94 38.59 33.73  31.29 18.72 14.75  33.87 15.02 14.52  26.88 18.25 11.93 3.40 <0.01 <0.01 0.26 
C20:4n6 0.986 0.247 0.233  0.401 0.737 0.070  0.188 0.991 0.637  0.955 3.259 3.11 0.64 0.37 <0.01 0.22 
C20:5n3 5.16 8.62 5.12  6.57 12.74 13.08  4.77 12.64 10.32  5.24 12.14 9.81 1.47 <0.01 <0.01 0.25 
C21:0 3.37 1.63 0.99  1.88 0.55 0.20  1.57 1.78 1.14  1.22 1.45 0.71 0.62 0.04 0.12 0.52 
C22:0 3.71 2.68 3.81  2.07 1.55 2.18  2.30 2.88 2.44  2.69 1.45 2.86 0.82 0.46 0.16 0.92 
C22:5n3 2.95 2.12 3.11  3.66 1.23 3.05  1.22 2.27 1.35  3.33 4.22 3.81 0.80 0.77 0.01 0.32 
C22:6n3 6.50 6.22 5.53  3.72 4.05 2.64  4.18 2.81 2.48  2.00 3.24 1.91 0.96 0.30 <0.01 0.90 
C24:0 1.46 3.91 2.46  3.01 1.76 2.31  2.05 1.69 1.88  1.72 1.95 1.33 0.79 0.89 0.64 0.40 
C24:1 2.49 1.63 1.10  1.72 1.46 1.72  1.35 1.03 1.58  2.03 2.38 2.31 0.58 0.78 0.28 0.76 
Total 1307 1217 1202  1644 1381 1489  1359 1442 1345  1238 1238 1290 102 0.78 <0.01 0.25 
§
SO = Soy Oil, Flax = Flaxseed, UFCP = Flaxseed treated with urea formaldehyde condensation polymer. 
¥ 
Interaction between diet and days on feed. 
†
DOF = Days on feed
 
₤
Effect of diet, days on feed, and interaction between diet and days on feed
 
P-values
 
protected by an overall F-test ≤ 0.05 
‡
Number after C denotes number of Carbons; n denotes the double bond location from the omega position; c and t denote the cis or trans configuration. 
a,b,c
Means within a row without common superscripts are different (P ≤ 0.05). 
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Table 5. Effect of diet on plasma concentrations of fatty acids expressed as a percent of total plasma fatty acids reported on an as-is basis.
§
  
Fatty acid, 
% of total
‡
 
d 0  d 28  d 56  d 84  P-value
₤
 
SO Flax UFCP  SO Flax UFCP  SO Flax UFCP  SO Flax UFCP SEM Diet DOF
†
 D×DOF
¥
 
C12:0 0.131 0.249 0.183  0.082 0.153 0.078  0.142 0.119 0.091  0.119 0.130 0.124 0.051 0.37 0.18 0.85 
C14:0 0.173 0.110 0.139  0.142 0.140 0.202  0.137 0.258 0.389  0.107 0.228 0.197 0.081 0.33 0.25 0.60 
C14:1 0.164 0.193 0.286  0.136 0.122 0.232  0.211 0.241 0.138  0.142 0.178 0.340 0.065 0.15 0.69 0.33 
C16:0 11.86 11.24 11.14  9.91 9.59 9.16  10.28 9.30 8.82  11.04 9.75 9.64 0.58 0.12 <0.01 0.96 
C16:1 1.596 1.661 1.77  0.764 1.396 1.16  0.311 0.929 0.765  0.242 0.202 0.217 0.181 0.04 <0.01 0.41 
C17:0 0.738 0.836 0.650  0.228 0.426 0.270  0.145 0.086 0.433  0.231 0.737 0.452 0.138 0.21 <0.01 0.18 
C17:1 0.430 0.493 0.454  0.229 0.184 0.228  0.245 0.179 0.179  0.293 0.341 0.151 0.074 0.58 <0.01 0.69 
C18:0 18.09
abc
 18.07
abc
 18.99
ab
  17.97
abcd
 17.57
abcdef
 17.00
cdefg
  17.80
abcde
 16.65
cdefg
 16.67
cdefg
  19.34
a
 15.39
g
 17.26
abcdefg
 0.76 0.17 <0.01 0.04 
C18:n1t9 2.01 1.96 2.29  1.88 1.08 1.40  1.43 0.97 0.95  1.10 0.84 0.92 0.22 0.11 <0.01 0.39 
C18:n1c9 7.56 7.19 6.67  5.26 6.44 5.80  6.21 6.70 6.09  5.41 6.85 5.27 0.41 0.02 <0.01 0.27 
C18:1n7 0.987 0.856 0.805  0.815 0.638 0.488  0.721 0.474 0.450  0.387 0.247 0.172 0.123 0.11 <0.01 0.98 
CLA c9, t11 0.243
a
 0.085
cde
 0.165
abcde
  0.127
abcde
 0.071
de
 0.078
cde
  0.063
e
 0.190
abc
 0.095
cde
  0.180
abcd
 0.163
abcde
 0.228
ab
 0.044 0.78 0.02 0.04 
CLA t10, 
c12 
0.259 0.166 0.096  0.056 0.175 0.041  0.066 0.071 0.036  0.100 0.064 0.111 0.058 0.49 0.06 0.35 
C18:2nt6 0.332 0.271 0.258  0.298 0.439 0.451  0.096 0.102 0.138  0.098 0.161 0.215 0.098 0.82 <0.01 0.94 
C18:2nc6 45.30
a
 47.28
abcd
 47.24
abc
  55.22
j
 47.15
ab
 48.15
abcdef
  54.75
j
 47.94
abcde
 48.84
abcdefghi
  54.80
j
 48.63
abcdefgh
 48.30
abcdefg
 1.43 <0.01 <0.01 <0.01 
C18:3n3 1.80
a
 1.08
a
 0.97
a
  1.71
a
 9.71
abcd
 10.91
def
  1.38
a
 11.58
fg
 11.50
efg
  1.20
a
 10.46
cd
 12.05
g
 0.36 <0.01 <0.01 <0.01 
C18:3n6 1.478
abcd
 1.759
a
 1.524
abc
  0.811
e
 0.834
e
 0.690
e
  1.538
ab
 0.737
e
 0.661
e
  0.910
e
 0.715
e
 0.449
e
 0.184 0.10 <0.01 0.03 
C20:0 0.204 0.193 0.115  0.154 0.123 0.128  0.133 0.183 0.236  0.203 0.186 0.101 0.055 0.81 0.62 0.34 
C20:1 0.173 0.209 0.186  0.087 0.112 0.086  0.109 0.096 0.160  0.089 0.205 0.228 0.057 0.40 0.14 0.83 
C20:2 0.598 0.435 0.477  0.146 0.168 0.242  0.223 0.300 0.250  0.275 0.375 0.378 0.077 0.90 <0.01 0.51 
C20:3n6 3.33
a
 3.14
ab
 2.88
abc
  1.90
ef
 1.33
fg
 0.98
g
  2.48
cd
 0.97
g
 1.11
g
  2.09
de
 1.42
fg
 0.98
g
 0.22 <0.01 <0.01 0.04 
C20:4n6 0.073 0.019 0.020  0.022 0.056 0.007  0.012 0.071 0.054  0.080 0.293 0.208 0.054 0.32 <0.01 0.29 
C20:5n3 0.392 0.700 0.431  0.395 0.935 0.894  0.356 0.878 0.790  0.427 1.067 0.778 0.118 <0.01 0.04 0.45 
C21:0 0.257 0.130 0.093  0.119 0.044 0.013  0.115 0.098 0.084  0.093 0.116 0.063 0.048 0.09 0.05 0.63 
C22:0 0.288 0.222 0.320  0.127 0.128 0.148  0.174 0.223 0.207  0.216 0.108 0.225 0.065 0.48 0.06 0.90 
C22:5n3 0.217 0.164 0.242  0.226 0.093 0.198  0.090 0.189 0.100  0.276 0.345 0.339 0.063 0.86 <0.01 0.51 
C22:6n3 0.512 0.540 0.500  0.223 0.302 0.190  0.315 0.206 0.185  0.149 0.281 0.165 0.079 0.53 <0.01 0.79 
C24:0 0.112 0.324 0.203  0.180 0.139 0.176  0.144 0.108 0.161  0.143 0.134 0.159 0.056 0.35 0.31 0.38 
C24:1 0.182 0.120 0.091  0.102 0.106 0.116  0.096 0.069 0.123  0.146 0.213 0.173 0.044 0.98 0.11 0.63 
§
SO = Soy Oil, Flax = Flaxseed, UFCP = Flaxseed treated with urea formaldehyde condensation polymer. 
₤
Effect of diet, days on feed, and interaction between diet and days on feed
 
P-values
 
protected by an overall F-test ≤ 0.05 
¥ 
Interaction between diet and day. 
†
DOF = Days on feed
 
‡
Number after C denotes number of Carbons; n denotes the double bond location from the omega position; c and t denote the cis or trans configuration. 
a,b,c
Means within a row without common superscripts are different (P ≤ 0.05). 
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Table 6. Effect of diet on longissimus muscle concentrations of fatty acids reported on an 
as-is basis.
§
 
Fatty acid, 
mg/kg
‡
 
Treatments  
Soy Oil Flax UFCP SEM P-value
₤
 
C14:0 0.307 0.260 0.213 0.037 0.08 
C14:1 0.046 0.040 0.170 0.010 0.10 
C16:0 2.13 1.93 1.67 0.23 0.25 
C16:1 0.346
a  
    0.288
ab
      0.206
b 
     0.040       0.02 
C17:0 0.093     0.096     0.093     0.003       0.75 
C17:1 0.068     0.064     0.049     0.009       0.24 
C18:0 1.11       1.12       1.07       0.12       0.96 
C18:n1t9 0.269 0.181 0.221 0.026 0.07 
C18:n1c9 2.77 2.69 2.34 0.29 0.49 
C18:1n7 0.136 0.132 0.119 0.016 0.72 
CLA c9, t11   0.0034
a
     0.0003
b
     0.0019
a
   0.0007   0.01 
CLA t10, c12 0.0006 0.0002 0.0011 0.0003 0.09 
C18:2nt6 0.017
a
 0.029
b
 0.023
ab
 0.003 0.02 
C18:2nc6 0.385 0.327 0.346 0.024 0.09 
C18:3n3   0.024
a
     0.083
b
     0.085
b
   0.075 <0.01 
C18:3n6   0.003     0.003 0.002 0.0008 0.44 
C20:0 0.005     0.009     0.010     0.002       0.07 
C20:1 0.018     0.016 0.015     0.002       0.63 
C20:2 0.006     0.005     0.005     0.0007       0.22 
C20:3n6 0.012    0.011     0.007  0.002       0.08 
C20:4n6 0.002
a
     0.003
b
     0.004
b
     0.0005       <0.01 
C20:5n3   0.002     0.003     0.002   0.0008   0.42 
C21:0 0.021     0.014     0.018     0.003       0.36 
C22:0 0.003     0.004     0.004     0.0007       0.86 
C22:5n3   0.004     0.002     0.002   0.0008   0.07 
C22:6n3   0.003     0.006     0.001   0.002   0.08 
C24:0 0.003     0.003 0.002 0.0005       0.12 
C24:1 0.0009     0.0011     0.0008     0.0003       0.72 
Total 7.63      7.16       6.36       0.74       0.41 
omega-3
d
 0.031
a
     0.092
b
     0.089
b
     0.008       <0.01 
omega-6
e
 0.424      0.374 0.385 0.027 0.22 
n-6:n-3
f
   17.69
a
       3.97
b
 4.18
b
  1.22   <0.01 
SFA
g
 3.70       3.45       3.10      0.39       0.44 
MUFA
h
 3.62       3.39       2.94       0.35       0.35 
PUFA
i
 0.463      0.473      0.480      0.033       0.89 
PUFA:SFA
j
 0.116 0.128 0.146 0.009 0.06 
§
SO = Soy Oil, Flax = Flaxseed, UFCP = Flaxseed treated with urea formaldehyde condensation polymer.
 
₤
Effect of diet P-value
 
protected by an overall F-test ≤ 0.05. 
a,b,c
 Means within a row without common superscripts are different (P ≤ 0.05). 
‡
Number after C denotes number of Carbons; n denotes the double bond location from the omega position; c and t 
denote the cis or trans configuration.  
d
omega-3= C18:3n3 + C20:5n3 + C22:5n3 + C22:6n3 
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e
omega-6 = C18:2nt6 + C18:2nc6 + CLAc9t11 + CLAt10c12 + C18:3n6 + C20:3n6 + C20:4n6  
f
n-6:n-3 = as omega-6 / omega-3 
g
SFA = C14:0 + C16:0 + C17:0 + C18:0 + C20:0 + C21:0 + C22:0 + C24:0 
h
MUFA = C14:1 + C16:1 + C17:1 + C18:1nt9 + C18:1n11 + C18:1nc9 + C18:1n7 + C20:1 + C24:1 
i
PUFA = C18:2n6t + C18:2n6c + CLAc9t11 + CLAt10c12 + C18:3n6 + C18:3n3 + C20:2 + C20:3n6 + C20:4n6 + 
C20:5n3 + C22:5n3 + C22:6n3 
j
PUFA:SFA = PUFA / SFA 
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Table 7. Effect of diet on longissimus muscle concentrations of fatty acids expressed as a 
percent of total fatty acids reported on an as-is basis.
§
 
Fatty acid, 
% of total
‡
 
Treatments  
Soy Oil Flax UFCP SEM P-value
₤
 
C14:0 3.78
a
       3.47
ab
       3.11
b
       0.20       0.02 
C14:1 0.558       0.561       0.250       0.126 0.11 
C16:0 27.39
a
       26.48
ab
       25.50
b
       0.46       <0.01 
C16:1 4.12
a
       3.83
ab
       3.03
b
       0.31       0.04 
C17:0 1.22       1.29       1.46       0.16       0.39 
C17:1 0.874      0.900      0.760      0.065       0.23 
C18:0 14.82       15.49       17.05       0.67       0.06 
C18:n1t9 3.60
a
      2.52
b
      3.62
a
      0.33 0.03 
C18:n1c9   35.63 36.90 35.67 0.92 0.35 
C18:1n7 1.51     1.55 1.56 0.20 0.97 
CLA c9, t11 0.040
a
     0.016
b
     0.030
a
     0.008       <0.01 
CLA t10, c12 0.009 0.003 0.020 0.006 0.10 
C18:2nt6 0.195
a
     0.383
b
     0.342
b
     0.046 <0.01 
C18:2nc6 4.63 4.11 4.94 0.31 0.09 
C18:3n3 0.317
a
      1.164
b
      1.358
b
     0.102 <0.01 
C18:3n6 0.043      0.037      0.032      0.013       0.81 
C20:0 0.059
a
      0.124
b
      0.147
b
      0.022       0.02 
C20:1 0.233      0.213      0.226      0.023       0.77 
C20:2 0.083      0.069     0.078     0.011       0.68 
C20:3n6 0.172      0.157      0.109      0.028       0.23 
C20:4n6 0.024
a
     0.039
ab
     0.058
b
     0.007       <0.01 
C20:5n3 0.023      0.037      0.034      0.013       0.70 
C21:0 0.265      0.196      0.273      0.032       0.16 
C22:0 0.049      0.058      0.059      0.013       0.83 
C22:5n3 0.045      0.021      0.022 0.010 0.21 
C22:6n3 0.051      0.095      0.024      0.026       0.14 
C24:0 0.043     0.039     0.028     0.009       0.47 
C24:1 0.010     0.014     0.009     0.005       0.76 
omega-3
d
 0.400
a 
     1.282
b
     1.40
b
      0.108       <0.01 
omega-6
e
 5.11       4.72 5.52 0.344 0.15 
SFA
f
 47.48       47.00 47.48 0.96 0.87 
MUFA
g
 46.59       46.53 45.19 0.98 0.31 
PUFA
h
 5.62
a
       6.10
a 
     7.04
b
       0.44       0.03 
§
SO = Soy Oil, Flax = Flaxseed, UFCP = Flaxseed treated with urea formaldehyde condensation polymer.
 
₤
Effect of diet P-value
 
protected by an overall F-test ≤ 0.05. 
a,b,c
Means within a row without common superscripts are different (P ≤ 0.05). 
‡
Number after C denotes number of Carbons; n denotes the double bond location from the omega position; c and t 
denote the cis or trans configuration.  
d
omega-3= C18:3n3 + C20:5n3 + C22:5n3 + C22:6n3 
e
omega-6 = C18:2nt6 + C18:2nc6 + CLAc9t11 + CLAt10c12 + C18:3n6 + C20:3n6 + C20:4n6  
f
SFA = C14:0 + C15:0 + C16:0 + C17:0 + C18:0 + C20:0 + C21:0 + C22:0 + C24:0 
g
MUFA = C14:1 + C16:1 + C17:1 + C18:1nt9 + C18:1n11 + C18:1nc9 + C18:1n7 + C20:1 + C24:1 
40 
h
PUFA = C18:2n6t + C18:2n6c + CLAc9t11 + CLAt10c12 + C18:3n6 + C18:3n3 + C20:2 + C20:3n6 + C20:4n6 + 
C20:5n3 + C22:5n3 + C22:6 
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Figure 1. Effect of diet, day, and the interaction between diet and day on plasma 
concentrations of fatty acids reported on an as-is basis. 
Soy Oil ▬♦▬; Flaxseed - ▲ -; UFCP Flaxseed ▬×▬ 
A. Effect of diet, day, and the interaction between diet and day on plasma concentrations 
of Omega-3 fatty acids. 
B. Effect of diet, day, and the interaction between diet and day on plasma n-6:n-3 fatty 
acid ratio. 
C. Effect of diet, day, and the interaction between diet and day on plasma concentrations 
of monounsaturated fatty acids. 
D. Effect of diet, day, and the interaction between diet and day on plasma concentrations 
of polyunsaturated fatty acids. 
E. Effect of diet, day, and the interaction between diet and day on plasma concentrations 
of saturated fatty acids. 
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CHAPTER 3: Novel extrusion of flaxseed (LinPro) increases 
omega-3 fatty acids in plasma and longissimus muscle tissues 
from Holstein steers fed feedlot diets 
ABSTRACT 
Holstein steers (n = 30; initial BW = 499 ± 46 kg) were used in a finishing  
study to evaluate the effects of feeding linseed oil and a new extrusion of flaxseed and 
field peas on plasma and LM fatty acid (FA) profiles. Experimental treatments included 
corn-based diets containing soy oil (SO), linseed oil (LO), or a blend of flaxseed and field 
peas that were mixed and extruded (LinPro). These treatments were replicated across 10 
individually-fed steers per treatment. Residual feed, plasma FA profiles, and BW were 
determined every 28-d period. Steers were harvested after 89 and 119 d on feed (heavy 
and light blocks, respectively). Body weights were recorded prior to shipmen to the 
abattoir. Following a 48-h chill, full rib primals were collected and lean tissue was 
analyzed for FA profiles. Finishing performance and carcass quality were not affected by 
diet (P > 0.07). There was an interaction between diet and days on feed; plasma α-
linolenic acid (ALA) and total omega-3 FA increased (P < 0.01), and n-6:n-3 decreased 
(P < 0.01) after 28 DOF in response to feeding products containing flaxseed and 
plateaued thereafter. Cattle fed flaxseed products had increased LM ALA and total 
omega-3 FA, and decreased n-6:n-3 than cattle fed SO (P < 0.01). Cattle fed LinPro had 
greater increases in LM ALA and total omega-3 than cattle fed LO (P < 0.05). Including 
flaxseed products in finishing diets increases desirable FA in both plasma and LM. 
Changes in plasma ALA, total omega-3 FA and n-6:n-3 transpire quickly, occurring by d 
28 and throughout the trial. The novel feedstuff LinPro resulted in greatest levels of 
C18:3n3 and total omega-3 FA in LM. 
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Key words: beef, fatty acid, finishing, linseed meal, linseed oil 
Introduction 
Many Americans don’t consume the recommended amounts of n-3 fatty acids 
(Kris-Etherton et al., 2000). Americans eat a great deal more beef (81.6 g/d per capita; 
USDA-ERS, 2005) than fish (4.58 g/d per capita; EPA, 2002). Consequently, n-3 
enriched beef could be useful as an alternative source of omega-3 fatty acids (FA) in 
Western diets.  
Previous studies have investigated the use of forage diets to increase n-3 FA in 
beef (Lorenz et al., 2002). Most cattle in the U.S. are finished on grain-based diets, 
yielding beef products with organoleptic properties deemed desirable by U.S. consumers 
(Medeiros et al. 1987). Beef produced with conventional high grain diets generally 
contains relatively low levels of n-3 FA. Previous research has investigated feeding 
strategies aimed at altering FA composition of beef using fats with high n-3 content 
(Clinquart et al., 1991; Scollan et al., 2001). However, these fats often are altered by 
rumen microbes through biohydrogenation (BH), limiting n-3 FA assimilation and tissue 
deposition.  
Flaxseed is rich in the n-3 FA α-linolenic acid (ALA). Feeding flaxseed can 
increase concentrations of n-3 FA in lean tissues (Maddock et al., 2006; La Brune et al., 
2008), suggesting some FA escape BH. Similarly, Montgomery et al. (2008) also 
reported 22% of flax oil FA escapes BH. Protection of these FA against ruminal BH 
could increase FA that are available for deposition into edible tissues.  
Ruminal bypass of flaxseed FA has been achieved through extrusion (Raes et al., 
2004; Barton et al., 2007; Dawson et al., 2010). LinPro is a feedstuff composed of an 
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extruded mixture of flaxseed and field peas. The effects of LinPro on beef cattle 
performance and carcass traits have not been determined. Therefore the objectives of this 
study were to evaluate LinPro as a dietary method of increasing ruminal bypass of 
flaxseed FA and the subsequent effects on plasma FA profiles and muscle deposition of 
omega-3 FA in salable red meat. 
Materials and Methods 
This study was conducted in accordance with procedures approved by the Kansas 
State University Institutional Animal Care and Use Committee.  
Production of LinPro 
 LinPro is an extruded product produced using an approximated 50:50 
combination of full-fat flaxseed and split field peas (Oleet Processing Ltd., Regina, SK). 
The flaxseed and peas were extruded using an Instapro extruder (Instapro Inc., Des 
Moines, IA) for 20 to 25 s at a temperature of 125 to 130ºC.  
Animals and Diets 
Experimental treatments included corn-based diets containing soy oil at 4% (SO), 
linseed oil at 4% (LO), or LinPro at 16% of the diet DM (Table 1). Compositions of diets 
are summarized in Table 1. Table 2 reports the ingredient FA profiles. The ingredients 
soy oil and linseed oil were first mixed into an emulsion with salt, molasses, and xanthum 
gum before being added to the total mixed ration.  
To minimize differences in gastrointestinal tract fill, steers were fed a common 
diet based on dry-rolled corn for several d before initiation of the experiment. Cattle (n = 
30; initial BW = 499 ± 46 kg) were stratified by BW and randomly allocated to 1 of 4 
dietary treatments within each of the ten strata. The heaviest strata were allocated to the 
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first heaviest group. Steers were housed within barns consisting of 20 individual 
partially-covered concrete pens per barn; each pen measured 1.5 m × 6 m. On d 1, steers 
were implanted (Revalor XS, 200 mg of trenbolone acetate, 40 mg of estradiol; Intervet 
Inc., Millsboro, DE), dewormed (Safeguard; Intervet, Inc., Millsboro, DE), individually 
weighed and identified with uniquely numbered ear tags. Baseline blood samples were 
collected in heparinized vacuum tubes (BD; Franklin Lakes, NJ) via jugular puncture. 
Tubes were immediately placed onto ice before centrifuging at 3200 × g for 10 min to 
recover plasma. Every 28 d thereafter, cattle were weighed individually, unconsumed 
feed was weighed, and blood samples were collected for analyses of FA.  
Feed was offered ad libitum and delivered to individual fenceline feed bunks once 
daily at approximately 1300 h. Feed refusals were recorded every 28 d or as needed when 
excess residual feed accumulated in feed bunks. Dry matter intakes were calculated from 
the as-fed deliveries using actual feedstuff DM values, less the amount of unconsumed 
DM. Daily gain was calculated as kg of gain on a shrunk basis. Feed efficiency was 
calculated as kg of gain on a shrunk basis per kg of DM consumed. Water was offered ad 
libitum via automatic water fountains shared between adjacent pens.  
Harvest Data Collection and Sampling Procedures 
Steers were harvested on 2 d. The heavier weight block was slaughtered on d 89, 
and the lighter initial weight block was slaughtered on d 119. Final BW (gross BW × 
0.96) was determined before cattle were transported to a commercial abattoir (Holcomb, 
KS). Incidence and severity of liver abscesses and HCW were recorded the d of harvest. 
Incidence and severity of liver abscesses were scored according to the scoring system 
(Elanco, Greenfield, IN): 0 = no abscesses; A
−
 = 1 or 2 small abscesses or abscess scars; 
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A
0
 = 2 to 4 small, well-organized abscesses; and A
+
 = 1 or more large or active abscesses 
with or without adhesions. Carcass data were collected after a 24-h chill for the heavy 
block and after a 72-h chill for the light block. The boneless ribs from the 6
th
 through the 
12
th
 rib section were collected from the left side of each carcass. KPH, 12th rib fat 
thickness, LM area, marbling scores, USDA yield grades, and USDA quality grades were 
determined.  
Analyses of Plasma Fatty Acids 
Blood was collected from steers using heparinized tubes (BD, Franklin Lakes, NJ)  
18-h postfeeding on d 1 and at 28-d intervals thereafter. Tubes were immediately placed 
onto ice before centrifuging at 3,200 × g for 10 min to recover plasma. Plasma was freeze 
dried (500 ul) and combined with 1 mL benzene containing internal standard (1,000 
ug/mL methyl-C:13) and 4 mL BF3-Methanol reagent (Supelco B1252). Tubes were 
incubated at 60°C for 60 minutes and then cooled to room temperature. Hexane (1 mL) 
and ddH2O (4 mL) were added and tubes were vortexed. Tubes were then centrifuged at 
1000 × g for 5 min. The organic solvent layer (1 to 2 mL) was then analyzed via gas 
chromatography (Schimadzu model 17A, Palo Alto, CA) equipped with a Supelco SP-
2560 capillary (100m × 0.25 mm × 0.20u film) using He as the carrier gas at a flow rate 
of 1.1 mL/min. Initial temperature was 140°C for 4 min, followed by an increase of 
4°C/min to a final temperature of 240°C. 
Muscle Sample Analyses 
At collection, boneless ribs were placed into multipurpose plastic bags, 
transported to the Kansas State University Meats Laboratory, and refrigerated overnight 
at 0 ± 2°C. Rib sections were weighed and vacuum packaged in Nylon/PE Multivac bags 
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(Ultravac Solutions, Kansas City, MO) by using a Multivac vacuum packager (Multivac 
C500, Sepp Hagenmüller GnbH & Co, Germany). Vacuum was checked using a 
Kennedy Gauge (Kennedy Gauge, Kennedy Enterprises, Lincoln, NE) with an average 
vacuum reading of 0.7774 Bar. Vacuum packaged ribs were stored for an additional 16 d 
at 0 ± 2°C. Starting at the cranial end of the ribs, a steak (2.54 cm thick) was removed for 
analysis of long-chain fatty acid (LCFA) composition. Longissimus muscle LCFA 
profiles were analyzed following the procedures of Sukhija and Palmquist (1988). 
Briefly, 50 to 500 mg of samples were mixed with 2 mL internal standard in benzene and 
3 mL methabolic-HCl before being dried with nitrogen. Tubes were then capped and 
vortexed, heated for 2.25 hours at 80ºC, and vortexed every 45 min during heating. Tubes 
were cooled to room temperature and mixed with 5 mL 6% K2CO3 and 2 mL benzene 
while being vortexed. Tubes were centrifuged at 500 × g for 5 min. The organic solvent 
layer was then analyzed using a Schimadzu gas chromatography (model 17A; Schimadzu 
Corp., Palo Alto, CA) equipped with a Supelco SP-2560 capillary (100 m × 0.25 mm × 
0.20 um; Supelco Inc., Bellefonte, PA) using He as the carrier gas at a flow rate of 1.1 
mL/min. Initial temperature was 140°C for 4 min, and was increased by 4°C/min to a 
final temperature of 240°C.  
Statistical Analyses 
Plasma LCFA, LM LCFA, growth performance, and carcass characteristics were 
analyzed using the MIXED procedure of SAS (version 9.0, SAS Inst. Inc., Cary, NC). 
Animal was the experimental unit, diet was the fixed effect, and block was the random 
effect for analysis of plasma LCFA, LM LCFA, growth performance, and carcass 
characteristics. The statistical analysis of plasma LCFA also included diet × day and day 
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as fixed effects. USDA quality grade and liver abscesses were calculated and analyzed 
using Monte Carlo’s Chi Square analysis (Higgins, 2004) with animal as the 
experimental unit and block as the random effect. Ribs (n = 30; 10 per treatment) served 
as the experimental unit for LM LCFA analyses. Mean comparisons were determined 
following an F-test with P ≤ 0.05. Means were considered different at P-value ≤ 0.05, 
with a P-value of ≤ 0.10 considered as a tendency.  
Results & Discussion 
Performance and Carcass Characteristics 
Figure 2 demonstrates BW was not affected by diet throughout the trial. Finishing 
performance and carcass characteristic results are reported in Table 3. Performance 
variables and carcass quality were not affected (P ≥ 0.07) by treatment in the present 
study. This was expected as the diets were formulated with similar energy density and fat 
content. This agrees with several studies where extruded flaxseed (Raes et al., 2004; 
Barton et al., 2007; Dawson et al., 2010) did not affect performance or carcass traits.  
Fatty Acid Profiles 
 Plasma and LM FA compositions are reported as absolute values (Tables 3 and 5) 
and percent of the total FA (Tables 4 and 6). 
 There was an interaction between the effects of diet and day for plasma ALA and 
total omega-3 (P < 0.01). By d 28, flaxseed products induced greater (P < 0.05) plasma 
ALA and maintained the elevated levels throughout the study when compared to control 
cattle. When expressed as a percent of total FA, plasma ALA was further increased (P < 
0.05) in cattle fed LinPro compared to cattle fed LO or control diets on d 28 and 
throughout the trial. Feeding flaxseed products also increased plasma total omega-3 at d 
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28 and throughout the trial; however of the flaxseed products LinPro produced higher (P 
< 0.05) absolute levels of plasma total omega-3 on d 28, 56 and 84, and higher (P < 0.05) 
percent values of plasma total omega-3 on d 28, 56, 84, and 112 than LO. Steers fed 
flaxseed products had greater (P < 0.05) ALA and total omega-3 than control steers. This 
was expected as the flaxseed products provided more n-3 FA than the control diets (Table 
2). The extruded product LinPro induced greater (P < 0.05) levels of ALA and total 
omega-3 in LM tissues than cattle fed LO or control diets. These observations are 
consistent with previous studies where extruded flaxseed increased LM ALA and total 
omega-3 compared to control animals (Raes et al., 2004; Barton et al., 2007; Dawson et 
al., 2010). The current study’s observations demonstrate extrusion protects n-3 FA 
against BH and causes greater LM ALA and total omega-3 depositions than feeding 
unprotected n-3 FA.  
Plasma total omega-6 FA were affected by the interaction of diet and day when 
values were expressed as a percent of total FA, but not as absolute values. By d 28 and 
throughout the trial, flaxseed products produced lower (P < 0.01) levels of percent plasma 
total omega-6 than control cattle. The decrease in percent plasma total omega-6 was even 
greater (P < 0.05) on d 56 in cattle fed LinPro compared to LO. Feeding flaxseed 
products decreased (P < 0.01) percent of plasma total omega-6 compared to control 
cattle. Conversely, diet did not affect (P ≥ 0.13) levels of LM omega-6. These 
observations agree with Dawson et al. (2010) and Barton et al. (2007), but contrasts with 
results of Raes et al. (2004) where a decrease in LM omega-6 was observed when feeding 
extruded flaxseed. The current observations may be explained by the results of Brenner 
(1989), where it was shown that n-3 metabolism is preferred over n-6 metabolism. 
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Therefore, the presence of high n-3 FA, such as in flaxseed, could prevent the use of n-6 
FA as a substrate, subsequently preventing any decrease in n-6 FA.  
As a result of changes in omega-3 levels, the ratio between n-3 and n-6 FA was 
affected. Diet interacted with day (P < 0.01) so that n-6:n-3 decreased (P < 0.01) on d 28 
and throughout the trial in cattle fed flaxseed products compared to cattle fed the control 
diet. Both plasma and LM n-6:n-3 were decreased (P < 0.01) in steers fed flaxseed 
products compared to cattle fed the control diet. This is in agreement with Dawson et al. 
(2010) and Barton et al. (2007) where feeding extruded flaxseed was reported to decrease 
(P < 0.001) LM n-6:n-3.  
Fatty acid saturation (SFA, MUFA, PUFA, PUFA:SFA) was not affected (P ≥ 
0.08) by the interaction between diet and day. Diet did not affect (P ≥ 0.41) levels of SFA 
in LM tissues. Previous research has also shown that feeding extruded flaxseed does not 
affect muscle SFA compared control animals (Raes et al., 2004; Barton et al., 2007). 
Agreeing with previous research (Raes et al., 2004; Barton et al., 2007; Dawson et al., 
2010), diet did not affect (P ≥ 0.19) plasma or LM MUFA values. Percent of LM PUFA 
was affected (P = 0.02) by diet, although plasma PUFA and LM PUFA absolute values 
were not affected (P > 0.05). These results are in contrast to studies where extruded 
flaxseed inclusion did not affect muscle PUFA levels (Raes et al., 2004; Barton et al., 
2007). A diet effect on LM PUFA was not expected since concentrations of muscle 
PUFA are primarily impacted by genetics and are only minimally influenced by nutrition 
(De Smet et al., 2003).  
In plasma and LM tissues, PUFA:SFA was greater (P < 0.05) in steers fed 
flaxseed products than those fed SO. These results agree with Dawson et al. (2010), but 
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contrast Barton et al. (2007). Dawson et al. (2010) used double-muscled Belgium Blue 
bulls whereas Barton et al. (2007) used Limousin and Charolais steers, which may 
affected the degree of saturation of the FA profile. Even though LinPro increases n-3 FA 
in plasma and LM tissues, the extrusion process does not greatly affect biohydrogenation 
or the saturation of FA.  
Including flaxseed products in finishing diets can increase desirable FA in both 
plasma and LM. Changes in plasma ALA, omega-3 and n-6:n-3 occur quickly, as early as 
d 28 and remain affected throughout the trial. Feeding LinPro resulted in the greatest 
concentrations of ALA and total omega-3 FA in LM tissues. 
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Table 1. Composition of treatment diets on a DM basis.
a
 
 Treatments 
Item, % DM Soy Oil Linseed Oil  LinPro 
Ingredients    
    Dry rolled corn 70.87 70.87 62.75 
    Corn silage 9.99 9.99 10.00 
    LinPro - - 16.05 
    Soy oil   4.00 - - 
    Linseed oil  -   4.00 - 
    Corn steep liquor   3.00   3.00   3.00 
    Molasses 3.00 -   3.00 
    Soybean meal 4.05 4.05 - 
    Feed additive 1.96 1.96 1.96 
    Limestone 1.67 1.67 1.64 
    Urea, 46% N 1.01 1.01 1.01 
    Salt 0.30 0.30 0.30 
    Trace mineral premix 0.06 0.06 0.06 
    Vitamin premix 0.28 0.28 0.28 
Nutrients, %    
    DM 73.19 73.52 74.65 
    CP 12.67 13.15 13.41 
    P   0.46   0.49   0.48 
    Ca   0.72   0.72   0.74 
    Ether extract   7.61 6.17 7.04 
    NDF 10.43 10.43 11.22 
 
a
Formulated to provide provide 300 mg/d monensin, 90 mg/d tylosin 
(Elanco Animal Health, Greenfield, IN), 0.3% salt, 2650 IU vitamin A, 22 IU 
vitamin E, 0.10 mg Co, 10 mg Cu, 0.5 mg I, 0.25 mg Se, 50 mg Mn, and 50 
mg Zn per kg diet DM.  
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Table 2. Ingredient fatty acid profiles reported on an as-is basis. 
Fatty acid, % of 
sample
‡
 
Ingredient 
Soy Oil Linseed Oil LinPro 
No. of samples 3 3 3 
C10:0 0.007 0.018 0.003 
C11:0 0.002 0.007 0.004 
C12:0 0.001 0 0.001 
C14:0 0.018 0.002 0.002 
C14:1 0.006 0 0.002 
C15:0 0.009 0.028 0.002 
C15:1 0.088 0.006 0.002 
C16:0 4.309 5.030 1.459 
C16:1 0.003 0.021 0.005 
C17:0 0.003 0.026 0.002 
C17:1 0.028 0.120 0.012 
C18:0 1.706 3.544 0.813 
C18:1nt9 0.207 0.028 0.010 
C18:1nc9 
 
7.272 17.879 3.978 
C18:1n7 0.648 0.696 0.216 
CLA c9, t11 0.005 0.353 0.009 
CLA t10, c12 0.004 0 0.004 
C18:2nt6 0.004 0.004 0 
C18:2nc6 20.690 15.819 4.123 
C18:3n3 3.059 54.688 12.762 
C18:3n6 0.010 0.234 0.079 
C20:0 0.138 0.195 0.045 
C20:1 0.083 0.122 0.031 
C20:2 0.042 0.042 0.011 
C20:3n6 0.001 0.001 0.003 
C20:4n6 0.033 0.019 0.014 
C20:5n3 0.002 0.002 0.022 
C21:0 0.030 0 0 
C22:0 0.19 0.118 0.034 
C22:5n3 0.006 0.003 0.003 
C22:6n3 0 0 0.001 
C24:0 0.090 0.111 0.047 
C24:1 0.032 0.022 0.015 
omega-3
a
 3.067 54.694 12.788 
omega-6
b
 20.792 16.431 4.235 
SFA
c
 6.502 9.079 2.410 
MUFA
d
 0.241 0.291 0.067 
PUFA
e
 23.901 71.167 17.034 
‡
Number after C denotes number of Carbons; n denotes the double bond location from the 
omega position; c and t denote the cis or trans configuration.  
a
omega-3= C18:3n3 + C20:5n3 + C22:5n3 + C22:6n3 
60 
b
omega-6 = C18:2nt6 + C18:2nc6 + CLAc9t11 + CLAt10c12 + C18:3n6 + C20:3n6 + C20:4n6  
c
n-6:n-3 = omega-6 / omega-3 
d
SFA = C14:0 + C15:0 + C16:0 + C17:0 + C18:0 + C20:0 + C21:0 + C22:0 + C24:0 
e
MUFA = C14:1 + C16:1 + C17:1 + C18:1nt9 + C18:1n11 + C18:1nc9 + C18:1n7 + C20:1 + 
C24:1 
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Table 3. Effect of diet on performance and carcass characteristics.  
 Treatments  
Item Soy Oil Linseed Oil LinPro SEM P-value
§
 
Initial BW, kg 498.0  497.1     497.9  16.0 0.97 
Final BW
†
, kg 624.5     612.7      626.4 13.1 0.62 
DMI, kg/d 12.70       12.03 12.10 0.57 0.59 
ADG, kg/d 1.17       1.11 1.20       0.11 0.76 
G:F 0.091     0.093     0.100     0.007       0.65 
HCW, kg 393.7    389.5 392.5      7.9 0.34 
LM area, cm
2
 79.5      76.7 79.8 3.8 0.78 
Fat thickness, cm 0.55      0.47      0.50      0.08       0.68 
KPH, % 2.81       2.93       2.88       0.27 0.95 
Dressing percent 63.04 62.13 62.68 0.005 0.07 
Liver abcesses, %
¥
 0.0 10.0 0.0 - 1.00 
USDA yield grade 2.6       2.5
 
      2.4       0.2       0.59 
Marbling score
‡
 557      468      510      47 0.18 
Select, %
¥
 0.0 20.0 10.0 - 0.75 
Choice, %
¥
 75.0 80.0 70.0 - 1.00 
Upper Choice, %
¥
 37.5 40.0 20.0 - 0.68 
Prime, %
¥
 25.0 0.0 20.0 - 0.42 
†
Calculated as full BW × 0.96 
‡
300 to 399 = Slight, 400 to 499 = Small, 500 to 599 = Modest, 600 to 699= Moderate 
¥
Monte Carlo Exact Fit Chi Square Analysis (Higgins, 2004) 
a,b,c
 Means within a row without common superscripts are different (P ≤ 0.05) 
§ 
Effect of diet
 
P-value
 
protected by an overall F-test ≤ 0.05 
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Table 4. Effect of diet on plasma concentrations of fatty acids reported on an as-is basis.
§
  
Fatty acid, 
mg/L
‡
 
d 0  d 28  d 56  d 84   P-value
₤
 
SO LO LP  SO LO LP  SO LO LP  SO LO LP SEM Diet DOF
†
 D×DOF
¥
 
C12:0 1.73 3.10 1.31  1.31 1.77 1.53  1.81 1.68 1.42  1.22 1.78 1.41 0.61 0.22 0.63 0.79 
C14:0 2.39 2.24 1.32  2.27 2.53 4.98  1.92 3.13 5.21  1.40 2.25 0.98 0.57 0.44 0.03 0.10 
C14:1 2.36 1.94 2.07  2.28 3.33 3.44  2.74 3.49 2.82  1.80 4.70 2.43 0.81 0.21 0.39 0.41 
C16:0 153.6 147.0 147.1  162.7 141.1 149.4  139.4 118.0 120.4  140.0 128.7 102.9 7.76 0.02 <0.01 0.09 
C16:1 21.07 20.17 23.58  12.64 19.87 21.93  4.16 13.12 9.62  3.43 3.52 0.67 1.26 2.33 <0.01 0.06 
C17:0 10.02 7.62 6.52  4.71 6.96 6.97  1.98 5.57 2.61  3.07 9.64 6.82 1.89 0.16 0.02 0.28 
C17:1 5.43 8.60 8.05  3.64 3.78 5.06  3.29 4.24 3.26  3.50 3.88 2.51 1.14 0.34 <0.01 0.58 
C18:0 235.6 241.3 228.7  295.6 264.3 267.6  241.6 229.1 223.9  248.0 217.9 196.1 15.01 0.22 <0.01 0.45 
C18:n1t9 26.28 28.48 24.73  31.49 24.18 21.07  19.36 10.68 16.43  13.94 13.71 11.98 3.28 0.25 <0.01 0.30 
C18:n1c9 96.98 89.88 94.60  86.83 108.42 104.35  84.71 89.49 85.76  68.90 81.48 68.47 6.25 0.40 <0.01 0.11 
C18:1n7 12.98 11.12 10.32  13.53 11.43 10.09  9.87 5.15 4.39  4.92 4.95 4.51 1.79 0.16 <0.01 0.75 
CLA c9, t11 3.16 1.86 0.96  2.05 0.21 0.76  0.89 2.05 0.92  2.25 1.40 1.75 0.29 0.56 0.08 0.06 
CLA t10, c12 3.14
a
 0.28
b
 1.24
b
  0.90
b
 0.68
b
 0.70
b
  0.89
b
 1.05
b
 0.66
b
  1.38
b
 1.23
b
 0.88
b
 0.33 0.50 0.17 0.04 
C18:2nt6 4.37 4.95 3.95  4.88 9.92 6.47  1.25 2.50 0.85  1.83 1.76 2.32 0.59 0.11 <0.01 0.40 
C18:2nc6 595.4 631.6 576.0  906.1 792.3 758.5  745.3 707.6 662.2  703.2 686.6 610.6 42.2 0.20 <0.01 0.18 
C18:3n3 24.01
abcde
 19.11
abc
 22.15
abcd
  27.97
abcdef
 132.74
ghi
 167.01
j
  18.66
ab
 117.85
g
 168.04
j
  15.53
a
 123.69
gh
 157.24
ij
 10.20 <0.01 <0.01 <0.01 
C18:3n6 19.77
abc
 18.28
abcd
 21.52
a
  13.57
cde
 12.53
defg
 12.99
def
  20.45
ab
 7.45
efgh
 7.35
efgh
  11.52
efgh
 6.43
h
 5.22
h
 2.37 0.01 <0.01 0.02 
C20:0 2.76 2.28 2.68  2.54 1.21 1.58  1.73 1.76 1.67  2.56 2.69 1.14 0.64 0.57 0.18 0.40 
C20:1 2.55 1.74 1.84  1.43 1.39 1.25  1.39 1.72 0.91  1.05 3.53 1.32 0.84 0.45 0.56 0.52 
C20:2 7.47 5.51 4.69  2.33 4.25 4.35  2.91 4.08 4.91  3.36 3.24 4.84 1.00 0.67 0.01 0.12 
C20:3n6 42.94
a
 42.01
ab
 39.54
abc
  31.29
cde
 18.66
fgh
 20.43
fg
  33.87
bcd
 15.21
gh
 15.49
gh
  26.88
def
 17.43
gh
 12.47
h
 3.06 <0.01 <0.01 0.05 
C20:4n6 0.986 1.443 0.666  0.401 0.409 0.644  0.188 1.201 0.851  0.955 1.447 2.705 0.35 0.58 0.06 0.47 
C20:5n3 5.16 8.60 7.61  6.57 9.30 13.03  4.77 9.30 12.96  5.24 10.86 12.80 1.39 <0.01 0.03 0.16 
C21:0 3.37 2.73 1.95  1.88 0.47 0.94  1.57 1.78 0.86  1.22 1.63 1.39 0.68 0.30 0.02 0.74 
C22:0 3.71 3.52 2.15  2.07 2.04 1.26  2.30 0.92 1.72  2.69 1.82 1.67 0.38 0.74 0.06 0.82 
C22:5n3 2.95 3.69 2.65  3.66 2.56 0.98  1.22 2.52 1.50  3.33 3.55 3.07 0.75 0.12 0.04 0.48 
C22:6n3 6.50 6.41 6.92  3.72 3.93 5.54  4.18 2.19 2.86  2.00 2.44 2.01 0.91 0.68 <0.01 0.56 
C24:0 1.46 3.00 3.42  3.01 2.96 3.02  2.05 2.65 1.56  1.72 4.26 2.23 0.82 0.17 0.53 0.41 
C24:1 2.49 1.99 1.61  1.72 2.02 1.68  1.35 2.00 1.30  2.03 2.12 1.73 0.55 0.45 0.69 0.96 
Total 1307 1325 1253  1644 1589 1600  1359 1368 1363  1280 1349 1227 72 0.82 <0.01 0.74 
§
SO = Soy Oil, LO = Linseed Oil, LP = LinPro. 
₤
Effect of diet, days on feed, and interaction between diet and days on feed
 
P-values
 
protected by an overall F-test ≤ 0.05 
†
DOF = Days on feed 
¥ 
Interaction between diet and days on feed
 
‡
Number after C denotes number of Carbons; n denotes the double bond location from the omega position; c and t denote the cis or trans configuration. 
a,b,c
Means within a row without common superscripts are different (P ≤ 0.05). 
 
 
 
 
 
 
 
63 
 
 
 
Table 5. Effect of diet on plasma concentrations of fatty acids expressed as a percent of total plasma fatty acids reported on an as-is basis.
§ 
 
Fatty acid, 
% of total
‡
 
d 0  d 28  d 56  d 84   P-value
₤
 
SO LO LP  SO LO LP  SO LO LP  SO LO LP SEM Diet DOF D×DOF
¥
 
C12:0 0.131 0.236 0.103  0.082 0.119 0.089  0.142 0.116 0.107  0.119 0.126 0.105 0.046 0.30 0.42 0.74 
C14:0 0.173 0.176 0.102  0.142 0.166 0.315  0.137 0.232 0.365  0.107 0.172 0.080 0.071 0.49 0.06 0.10 
C14:1 0.164 0.154 0.161  0.136 0.209 0.214  0.211 0.273 0.195  0.142 0.363 0.195 0.060 0.20 0.30 0.39 
C16:0 11.86
a
 11.11
abc
 11.72
ab
  9.91
def
 8.93
fgh
 9.32
efgh
  10.28
cde
 8.69
gh
 8.90
fgh
  11.04
abcd
 9.60
efg
 8.31
h
 0.41 <0.01 <0.01 0.04 
C16:1 1.596
ab
 1.528
abc
 1.872
a
  0.764
fg
 1.245
bcde
 1.390
bcd
  0.311
hi
 0.974
def
 0.683
fgh
  0.241
i
 0.317
hi
 0.057
i
 0.160 0.02 <0.01 0.04 
C17:0 0.738 0.570 0.523  0.278 0.481 0.451  0.145 0.426 0.206  0.231 0.715 0.538 0.135 0.16 <0.01 0.24 
C17:1 0.430 0.708 0.621  0.229 0.233 0.316  0.245 0.307 0.257  0.293 0.324 0.208 0.097 0.38 <0.01 0.65 
C18:0 18.09
abcd
 18.29
ab
 18.23
abc
  17.97
bcde
 16.52
efg
 16.63
defg
  17.80
bcdef
 16.75
cdefg
 16.49
efg
  19.34
a
 16.27
fg
 16.01
g
 0.57 <0.01 0.01 0.03 
C18:n1t9 2.01 2.11 2.01  1.88 1.48 1.31  1.43 0.77 1.20  1.10 1.00 0.99 0.20 0.16 <0.01 0.35 
C18:n1c9 7.56
ab
 6.85
abc
 7.63
a
  5.26
g
 6.77
abcd
 6.57
bcde
  6.21
cdefg
 6.57
bcdef
 6.34
cdefg
  5.41
g
 6.13
cdefg
 5.63
defg
 0.40 0.37 <0.01 0.05 
C18:1n7 0.987 0.834 0.830  0.815 0.712 0.633  0.721 0.358 0.346  0.387 0.376 0.378 0.12 0.21 <0.01 0.69 
CLA c9, t11 0.243 0.139 0.086  0.127 0.013 0.051  0.063 0.152 0.070  0.180 0.109 0.153 0.04 0.17 0.02 0.10 
CLA t10, c12 0.259
a
 0.021
b
 0.110
b
  0.056
b
 0.047
b
 0.048
b
  0.066
b
 0.078
b
 0.047
b
  0.010
b
 0.096
b
 0.079
b
 0.040 0.10 0.05 0.03 
C18:2nt6 0.332 0.365 0.314  0.298 0.632 0.422  0.096 0.182 0.069  0.165 0.123 0.193 0.088 0.20 <0.01 0.37 
C18:2nc6 45.30
a
 47.25
abc
 45.87
ab
  55.22
j
 50.01
defg
 47.46
abcd
  54.75
ij
 51.64
efghi
 48.39
abcde
  54.79
ij
 50.60
defgh
 49.60
cdef
 1.22 <0.01 <0.01 <0.01 
C18:3n3 1.80
abcdef
 1.42
abc
 1.77
abcde
  1.71
abcd
 8.32
g
 10.42
j
  1.38
ab
 8.58
gh
 12.30
k
  1.20
a
 9.00
ghi
 12.94
k
 0.50 <0.01 <0.01 <0.01 
C18:3n6 1.478
abc
 1.452
abcd
 1.721
a
  0.811
ef
 0.795
ef
 0.809
ef
  1.538
ab
 0.559
ef
 0.547
ef
  0.910
e
 0.482
ef
 0.426
f
 0.17 0.02 <0.01 <0.01 
C20:0 0.204 0.182 0.210  0.154 0.080 0.097  0.133 0.131 0.125  0.203 0.192 0.088 0.047 0.61 0.04 0.53 
C20:1 0.173 0.131 0.145  0.087 0.085 0.074  0.109 0.123 0.061  0.089 0.258 0.114 0.062 0.52 0.33 0.64 
C20:2 0.598 0.424 0.379  0.146 0.265 0.268  0.223 0.289 0.377  0.275 0.251 0.395 0.081 0.70 <0.01 0.15 
C20:3n6 3.33
a
 3.20
ab
 3.15
abc
  1.90
ef
 1.14
g
 1.26
g
  2.48
d
 1.13
g
 1.16
g
  2.09
de
 1.27
g
 1.00
g
 0.20    <0.01 <0.01 0.04 
C20:4n6 0.073 0.099 0.053  0.022 0.029 0.035  0.012 0.078 0.053  0.080 0.106 0.225 0.042 0.29 <0.01 0.34 
C20:5n3 0.392 0.685 0.615  0.395 0.612 0.815  0.356 0.670 0.968  0.427 0.888 1.042 0.113   <0.01 0.04 0.29 
C21:0 0.257 0.209 0.161  0.119 0.032 0.057  0.115 0.127 0.071  0.093 0.123 0.122 0.052 0.49 <0.01 0.83 
C22:0 0.289 0.305 0.177  0.127 0.132 0.083  0.174 0.070 0.127  0.216 0.127 0.129 0.061 0.24 0.02 0.78 
C22:5n3 0.217 0.291 0.220  0.226 0.166 0.065  0.090 0.190 0.113  0.276 0.270 0.259 0.061 0.28 0.01 0.68 
C22:6n3 0.512 0.509 0.554  0.229 0.238 0.344  0.315 0.163 0.205  0.149 0.175 0.167 0.068 0.60 <0.01 0.66 
C24:0 0.112 0.233 0.292  0.180 0.194 0.201  0.144 0.195 0.119  0.143 0.331 0.201 0.065 0.20 0.46 0.43 
C24:1 0.182 0.155 0.134  0.102 0.125 0.100  0.096 0.146 0.097  0.146 0.150 0.150 0.038 0.65 0.28 0.96 
§
SO = Soy Oil, LO = Linseed Oil, LP = LinPro.
 
₤
Effect of diet, days on feed, and interaction between diet and days on feed
 
P-values
 
protected by an overall F-test ≤ 0.05 
†
DOF = Days on feed 
¥ 
Interaction between diet and days on feed
 
‡
Number after C denotes number of Carbons; n denotes the double bond location from the omega position; c and t denote the cis or trans configuration.  
a,b,c
 Means within a row without common superscripts are different (P ≤ 0.05). 
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Table 6. Effect of diet on longissimus muscle concentrations of fatty acids reported on an 
as-is basis. 
Fatty acid, 
mg/kg
‡
 
Treatments  
Soy Oil Linseed Oil LinPro SEM P-value
§
 
C14:0 0.284      0.219      0.213 0.038       0.27 
C14:1 0.046 0.031      0.028      0.012       0.49 
C16:0 2.107 1.747       1.793       0.244       0.45 
C16:1 0.357      0.269      0.291      0.044       0.20 
C17:0 0.093    0.100     0.097     0.005       0.50 
C17:1 0.069     0.054     0.048     0.009 0.15 
C18:0 1.18     1.11 1.16 0.136 0.90 
C18:1nt9 0.274
a
      0.185
b
      0.204
ab
      0.028       0.04 
C18:1nc9 
 
2.82       2.37       2.44       0.29       0.43 
C18:1n7 0.135      0.098      0.110      0.015       0.21 
CLA c9, t11 0.0034
a
     0.0001
b
     0.0007
b
     0.0004       <0.01 
CLA t10, c12 0.0006     0.0002     0.0005     0.0002       0.35 
C18:2nt6 0.014
a
     0.025
b
     0.028
b
    0.003       <0.01 
C18:2nc6 0.339      0.301      0.293      0.024       0.31 
C18:3n3 0.015
a
     0.057
b
     0.089
c
     0.010       <0.01 
C18:3n6 0.003     0.002     0.003    0.0007       0.37 
C20:0 0.005
a
     0.011
b
     0.011
b
     0.002       <0.01 
C20:1 0.018     0.013     0.015     0.002       0.08 
C20:2 0.006
a
     0.004
b
 0.006
a
     0.0008       0.04 
C20:3n6 0.012     0.009    0.010     0.002       0.45 
C20:4n6 0.001
a
     0.002
b 
    0.003
c 
    0.0004       <0.01 
C20:5n3 0.002     0.003     0.001     0.0008       0.17 
C21:0 0.021
a
     0.009
b
     0.019
a
     0.003       <0.01 
C22:0 0.003     0.003     0.004     0.0006       0.24 
C22:5n3 0.003     0.003     0.002     0.0008       0.33 
C22:6n3 0.003     0.005     0.006     0.002       0.53 
C24:0 0.0030
a
     0.0024
ab
     0.0019
b
     0.0003       0.05 
C24:1 0.009     0.009     0.001     0.0004       0.96 
Total 7.83       6.65       6.90       0.81       0.47 
omega-3
d
 0.023
a
 0.067
b
 0.099
c
 0.010 <0.01 
omega-6
e
 0.374 0.340 0.340 0.026 0.53 
n-6:n-3
f
 17.69
a
 5.55
b
 3.64
b
 1.25 <0.01 
SFA
g
 3.70 3.21 3.31 0.42 0.59 
MUFA
h
 3.71 3.01 3.13 0.37 0.30 
PUFA
i
 0.398 0.406 0.438 0.033 0.63 
PUFA:SFA
j
 0.109
a
 0.130
ab
 0.138
b
 0.010 0.04 
§ 
Effect of diet
 
P-value
 
protected by an overall F-test ≤ 0.05. 
‡
Number after C denotes number of Carbons; n denotes the double bond location from the omega position; c and t 
denote the cis or trans configuration.  
a,b,c
 Means within a row without common superscripts are different (P ≤ 0.05). 
d
omega-3= C18:3n3 + C20:5n3 + C22:5n3 + C22:6n3 
e
omega-6 = C18:2nt6 + C18:2nc6 + CLAc9t11 + CLAt10c12 + C18:3n6 + C20:3n6 + C20:4n6  
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f
n-6:n-3 = omega-6 / omega-3 
g
SFA = C14:0 + C15:0 + C16:0 + C17:0 + C18:0 + C20:0 + C21:0 + C22:0 + C24:0 
h
MUFA = C14:1 + C16:1 + C17:1 + C18:1nt9 + C18:1n11 + C18:1nc9 + C18:1n7 + C20:1 + C24:1 
i
PUFA = C18:2n6t + C18:2n6c + CLAc9t11 + CLAt10c12 + C18:3n6 + C18:3n3 + C20:2 + C20:3n6 + C20:4n6 + 
C20:5n3 + C22:5n3 + C22:6n3 
j
PUFA:SFA = PUFA / SFA 
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Table 7. Effect of diet on longissimus muscle fatty acids expressed as a percentage of total 
fatty acids reported on an as-is basis.  
Fatty acid,  
% of total
‡
 
Treatments  
Soy Oil Linseed Oil LinPro SEM P-value
§
 
C14:0 3.45       3.18       2.89       0.19       0.12 
C14:1 0.558       0.475       0.364       0.136       0.57 
C16:0 26.66       26.07       25.62       0.56       0.40 
C16:1 4.16       3.71       3.75       0.28       0.39 
C17:0 1.19       1.52       1.38       0.18       0.29 
C17:1 0.874      0.836      0.668      0.080       0.13 
C18:0 14.82       16.03       16.30       0.68       0.25 
C18:1nt9 3.60       2.86       3.00
 
      0.25       0.09 
C18:1nc9 
 
36.56       36.23       36.29       0.66       0.93 
C18:1n7 1.74       1.53       1.64       0.25       0.78 
CLA c9, t11 0.044
a 
    0.003
b 
    0.011
b
     0.005       <0.01 
CLA t10, c12 0.009     0.004     0.009     0.004       0.62 
C18:2nt6 0.179
a 
     0.402
b 
     0.442
b
      0.044       <0.01 
C18:2nc6 4.36       4.64       4.37       0.32       0.68 
C18:3n3 0.198
a
      0.878
b
      1.382
c
      0.098       <0.01 
C18:3n6 0.034      0.022      0.023      0.013       0.66 
C20:0 0.037
a
      0.162
b 
     0.138
b
      0.029       <0.01 
C20:1 0.242      0.199      0.229      0.019       0.23 
C20:2 0.083
ab
      0.055
a
     0.099
b
      0.014       0.05 
C20:3n6 0.172      0.134      0.169      0.032       0.61 
C20:4n6 0.012
a
     0.032
b
     0.047
c
     0.007       <0.01 
C20:5n3 0.023      0.053      0.022      0.015       0.20 
C21:0 0.265
a 
     0.139
b
      0.295
a
      0.030       <0.01 
C22:0 0.040      0.045      0.064      0.015       0.37 
C22:5n3 0.034      0.035      0.007      0.015       0.17 
C22:6n3 0.051      0.073      0.098      0.028       0.46 
C24:0 0.039     0.036     0.026     0.007       0.32 
C24:1 0.013     0.013     0.015     0.005       0.91 
omega-3
d
 0.314
a
 1.050
b
 1.525
c
 0.105 <0.01 
omega-6
e
 4.82 5.25 5.08 0.35 0.59 
SFA
f
 46.68 47.39 46.97 0.89 0.84 
MUFA
g
 47.81 45.91 46.03 0.97 0.30 
PUFA
h
 5.18
a
 6.32
b
 6.66
b
 0.42 0.02 
§ 
Effect of diet
 
P-value
 
protected by an overall F-test ≤ 0.05. 
‡
Number after C denotes number of Carbons; n denotes the double bond location from the omega position; c and t 
denote the cis or trans configuration.  
a,b,c
Means within a row without common superscripts are different (P ≤ 0.05). 
d
omega-3= C18:3n3 + C20:5n3 + C22:5n3 + C22:6n3 
e
omega-6 = C18:2nt6 + C18:2nc6 + CLAc9t11 + CLAt10c12 + C18:3n6 + C20:3n6 + C20:4n6  
f
SFA = C14:0 + C16:0 + C17:0 + C18:0 + C20:0 + C21:0 + C22:0 + C24:0 
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g
MUFA = C14:1 + C15:1 + C16:1 + C17:1 + C18:1nt9 + C18:1n11 + C18:1nc9 + C18:1n7 + C20:1 + C24:1
i
PUFA 
= C18:2n6t + C18:2n6c + CLAc9t11 + CLAt10c12 + C18:3n6 + C18:3n3 + C20:2 + C20:3n6 + C20:4n6 + C20:5n3 
+ C22:5n3 + C22:6n3
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Figure 1. Effect of diet, day, and the interaction between diet and day on plasma 
concentrations of fatty acids reported on an as-is basis. 
Soy Oil ▬♦▬; Linseed Oil ▬ ■ ▬; LinPro ▬×▬ 
A. Effect of diet, day, and the interaction between diet and day on plasma concentrations 
of omega-3 fatty acids. 
B. Effect of diet, day, and the interaction between diet and day on plasma n-6:n-3 fatty 
acid ratio. 
C. Effect of diet, day, and the interaction between diet and day on plasma concentrations 
of monounsaturated fatty acids. 
D. Effect of diet, day, and the interaction between diet and day on plasma concentrations 
of polyunsaturated fatty acids. 
E. Effect of diet, day, and the interaction between diet and day on plasma concentrations 
of saturated fatty acids. 
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CHAPTER 4: Flaxseed products do not interact with 
exogenous steroids in finishing cattle 
ABSTRACT 
The effects of flaxseed products and exogenous steroids on performance, carcass 
quality, and plasma and LM fatty acid (FA) profiles were evaluated. In study 1, steers 
were fed diets with tallow (Con) or flaxseed (Flaxseed), implanted with Revalor S (Imp; 
Revalor S, 120 mg of trenbolone acetate, 24 mg of estradiol; Intervet Inc., Millsboro, 
DE) or not implanted (No Imp), resulting in four treatments: Con-Imp, Con-No Imp, 
Flaxseed-Imp, and Flaxseed-No Imp. In study 2, steers were fed diets including soy oil 
(Con) or flaxseed (Flaxseed), implanted with Revalor XS (Imp; Revalor XS, 200 mg of 
trenbolone acetate, 40 mg of estradiol; Intervet Inc., Millsboro, DE) or not implanted (No 
Imp), resulting in four treatments: Con-Imp, Con-No Imp, Flaxseed-Imp, and Flaxseed-
No Imp. Plasma samples were collected every 28 d. After a 48-h chill, full rib primals 
were collected. Plasma and lean tissues were analyzed for FA profiles. In study 3, heifers 
were fed diets with or without linseed meal (LSM) and management regimes with or 
without an estradiol/trenbolone acetate implant (Rev IH, 80 mg trenbolone acetate and 8 
mg estradiol; Intervet Inc, Millsboro, DE) and melengestrol acetate (MGA; Pfizer Animal 
Health; New York, NY). This resulted in four treatments, a conventional program 
consisting of Rev IH and MGA with no added LSM (Con-Conv); Rev IH and MGA with 
LSM (LSM-Conv); a nonhormone treated cattle (NHTC) program with no implant or 
MGA with no added LSM (Con-NHTC); and no implant or MGA with LSM (LSM-
NHTC). In all studies residual feed and BW were determined every 28 d period and prior 
to transport for harvest, and carcass quality was determined for each animal following a 
48-h chill. Interactions between diet and exogenous hormones occurred in study 1 
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tending to affect KPH (P = 0.08) and in study 2 affecting yield grade (YG; P = 0.03) and 
marbling scores (P = 0.04); however there were no interactions (P ≥ 0.12) in study 3. 
Feeding flaxseed improved YG (P < 0.01) and decreased BF (P < 0.01) compared to 
steers fed control diets in study 2. Exogenous hormones consistently improved (P ≤ 0.03) 
DMI, ADG, feed efficiency, and HCW; but also exerted inconsistent effects on YG, 
dressing percentage and KPH. The LM of cattle fed flaxseed had increased (P < 0.01) 
concentrations of α-linolenic acid and total omega-3 FA, and decreased (P < 0.01) n-6:n-
3 compared to control cattle. Contrary to our hypothesis, flaxseed products did not act as 
natural growth promoters in NHTC cattle.  
Key words: finishing, flaxseed, linseed meal, steroidal implant, MGA, fatty acids 
Introduction 
Flaxseed is rich in secoisolariciresinol diglycoside (SDG) and omega-3 fatty acids 
(FA) and is fed in many forms to livestock. There is evidence indicating gastrointestinal 
bacteria can convert SDG to estrogen-like compounds that are metabolically active in 
mammals (Clavel et al., 2005 and Thompson et al., 1991). Research shows this 
metabolism also occurs in goats (Zhou et al., 2009a). These estrogen-like metabolites 
affect lipid metabolism in diet-induced obese rats (Fukumitsu et al., 2008); increase 
skeletal muscle growth in rats (Zhou et al., 2009b); and interact with estradiol-17β 
implants to affect estrogen receptors and mass of digestive organs in sheep (O’Neil et al., 
2009), and alter liver mass and proteins (O’Neil et al., 2006). One study (Dunn et al., 
2003) reported that implanted steers fed without flaxseed had greater ADG than 
implanted steers fed flaxseed, whereas the non-implanted steers fed flaxseed had 
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numerically greater gains than the non-implanted steers without flaxseed, suggesting a 
potential hormonal effect of the flaxseed.  
Flaxseed is rich in α-linolenic acid (ALA) and has been recorded to increase 
concentrations of n-3 FA in beef (Maddock et al., 2006; La Brune et al., 2008). Beef 
enriched with n-3 FA could be a useful source of the essential FA to U.S. consumers 
given that many Americans do not consume the recommended amounts of n-3 FA (Kris-
Etherton et al., 2000).  
To our knowledge previous experiments have not studied the estrogenic effects of 
SDG, and how it may interact with exogenous hormones to affect growth in cattle. We 
assessed the interactions between ground flaxseed and implants on performance and 
carcass quality in studies 1 and 2. In study 2, we also evaluated the interactions between 
ground flaxseed and an implant on plasma and LM FA profiles. In study 3, LSM was fed 
to remove the effects of flaxseed oil so as to study only SDG and its interactions with 
exogenous steroids and the effects on performance and carcass quality.  
Materials and Methods 
This study was conducted in accordance with procedures approved by the Kansas 
State University Institutional Animal Care and Use Committee.  
Experiment 1 
Yearling steers were used in a 2 × 2 factorial arrangement to test the effects of 
ground flaxseed and estradiol/trenbolone acetate implants on feedlot performance and 
carcass quality. Steers (n = 246; initial BW = 396 kg) were housed in concrete-surfaced 
pens (36 m
2
) with 6 to 7 animals each. Pens provided overhead shade covering the 
fenceline bunk and half of each pen. Pens included automatic water fountains and 3.2 m 
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of bunk space. Starting d -14, cattle were fed transition diets to reduce variation in gut 
fill. Steers were blocked by previous treatment (once vs twice per d feeding) and assigned 
randomly to 1 of 4 finishing diet treatments: no implant with beef tallow (Control NI), no 
implant with 10% ground flaxseed (Flaxseed NI), Revalor-S implant with beef tallow 
(Control RevS), and Revalor-S implant with 10% ground flaxseed (Flaxseed RevS). 
Composition of diets is summarized in Table 1. 
On d 1, steers were weighed and implanted (Revalor S, 120 mg of trenbolone 
acetate, 24 mg of estradiol; Intervet Inc., Millsboro, DE) according to treatment. Diets 
(Table 1) were formulated to be isocaloric and isonitrogenous and were fed ad libitum 
once daily for 80 d. Water was offered ad libitum provided by an automatic water 
fountains. Weights of fresh feed were recorded daily. Dry matter composition of each 
diet was determined weekly to allow for determination of total feed consumption for each 
pen. Feed refusals were recorded every 28 d or when in excess. These amounts on a DM 
basis were subtracted from the total feed offered to determine actual feed intake for each 
pen of cattle.  
At the end of the finishing period, pen weights were recorded and cattle were 
transported to a commercial abattoir. At harvest carcass weights were recorded. After a 
24-h chill, subcutaneous fat thickness over the 12
th
 rib, LM area, KPH, USDA quality 
grade, and USDA yield grade were determined.  
Experiment 2 
Holstein steers (n = 40; initial BW = 499 ± 46 kg) were used in a randomized 
complete block experiment with a 2 × 2 factorial treatment arrangement to evaluate the 
effects of ground flaxseed and steroidal implants on feedlot performance, carcass quality 
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and fatty acid composition in plasma and LM. Experimental treatments included diets of 
dry rolled corn with soy oil or 10% ground flaxseed, with or without an 
estradiol/trenbolone acetate implant. This resulted in four treatments: soy oil with implant 
(Control Imp), soy oil without implant (Control No Imp), flaxseed diet with implant 
(Flaxseed Imp), and flaxseed diet without implant (Flaxseed No Imp). Composition of 
diets is summarized in Table 2.   
To minimize differences in gastrointestinal tract fill, steers were fed a common 
diet based on dry rolled corn for several d before initiation of the experiment. On d 1, 
steers were dewormed (Safeguard, Intervet Inc., Millsboro, DE), individually weighed, 
and identified with individually numbered ear tags on d 1. Baseline blood samples were 
collected in heparinized vacuum tubes (BD, Franklin Lakes, NJ) via jugular vein. Tubes 
were immediately placed onto ice before centrifuging at 3200 × g for 10 min to recover 
plasma. Every 28-d period cattle were weighed individually, residual feed collected, and 
blood samples collected. Cattle were blocked by individual BW and assigned randomly 
to 1 of 4 treatments. Steers were implanted (Revalor XS, 200 mg of trenbolone acetate, 
40 mg of estradiol; Intervet Inc., Millsboro, DE) according to treatment and then placed 
in 1 of 4 barns consisting of 20 individual partially-covered concrete pens per barn; each 
pen measuring 1.5 m × 6 m.  
Feed was offered ad libitum and delivered to individual fenceline feed bunks once 
daily. Weights of fresh feed were recorded daily. Orts were recorded every 28 d or as 
needed before the scheduled orts recording. Dry matter intakes were calculated from the 
as-fed deliveries using actual feedstuff DM values, less the amount of unconsumed DM. 
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Daily gain was calculated as pounds of gain on a shrunk basis. Feed efficiency was 
calculated as pounds of gain on a shrunk basis per pound of DM consumed.  
Water was offered ad libitum provided by automatic water fountains shared 
between two pens.  
The heavier initial weight blocks were slaughtered on d 89, and the lighter initial 
weight blocks were slaughtered on d 119. Final BW (gross BW × 0.96) were determined 
before cattle were transported to a commercial abattoir (Holcomb, KS). Incidence and 
severity of liver abscesses and HCW were recorded at harvest. Incidence and severity of 
liver abscesses were scored according to the scoring system (Brink et al., 1990): 0 = no 
abscesses, A
−
 = 1 or 2 small abscesses or abscess scars; A
0
 = 2 to 4 small; well-organized 
abscesses; and A
+
 = 1 or more large or active abscesses with or without adhesions. 
Carcass data were collected after a 24-h chill for the first shipment and after a 72-h chill 
for the second shipment. Boneless sections of the 6
th
 through 12th ribs were collected 
from the left side of each carcass. Marbling scores, 12
th
 rib fat thickness, KPH, LM area, 
USDA yield grades, and USDA quality grades were determined. Actual BW (shrunk) 
was used to determine dressing percentage.  
Blood was collected from steers 18-h postfeeding on d 1 and every subsequent 
28-d period. Blood was collected into heparinized vacuum tubes (BD, Franklin Lakes, 
NJ) and immediately placed onto ice before centrifuging at 3200 × g for 10 min to 
recover plasma. To analyze for plasma long chain FA (LCFA) composition, plasma was 
freeze dried (500 ul) and combined with 1 mL benzene containing internal standard 
(1000ug/mL methyl-C:13) and 4 mL BF3-Methanol reagent (Supelco B1252). Tubes 
were incubated at 60°C for 60 min and then cooled to room temperature. Hexane (1 mL) 
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and ddH20 (4 mL) were added and vortexed. Tubes were centrifuged at 1000 × g for 5 
min. The organic solvent layer (1-2 mL) was then analyzed via gas chromatograph 
(Schimadzu model 17A, Palo Alto, CA) equipped with a Supelco SP-2560 capillary 
(100m × 0.25 mm × 0.20u film) using He as the carrier gas at a flow rate of 1.1 mL/min. 
Initial temperature was 140°C for 4 min. This was followed by an increase of 4°C/min to 
a final temperature of 240°C. 
Boneless ribs were placed into multipurpose plastic bags at collection, transported 
to the Kansas State University Meats Laboratory, and refrigerated overnight at 0 ± 2°C. 
Rib sections were weighed and vacuum packaged in Nylon/PE Multivac bags (Ultravac 
Solutions, Kansas City, MO) using a Multivac vacuum packager (Multivac C500, Sepp 
Hagenmüller GnbH & Co, Germany). Vacuum was checked using a Kennedy Gauge 
(Kennedy Gauge, Kennedy Enterprises, Lincoln, NE) with an average vacuum reading of 
0.7774 Bar. Vacuum packaged ribs were stored for an additional 16 d at 0 ± 2°C. Starting 
at the cranial end of the ribs, a steak (2.54 cm thick) was removed for analysis of long-
chain fatty acid (LCFA) composition. Muscle LCFA profiles were analyzed following the 
procedures of Sukhija and Palmquist (1988). Briefly, 50 to 500 mg of samples were 
mixed with 2 mL internal standard in benzene and 3 mL methanolic-HCl before being 
flushed with nitrogen. Tubes were then capped and vortexed, heated for 2.25 h at 70ºC, 
and vortexed every 45 min during heating. Tubes were cooled to room temperature and 
mixed with 5 mL 6% K2CO3 and 2 mL benzene while being vortexed. Tubes were 
centrifuged at 500 × g for 5 min. The organic solvent layer was then analyzed using a 
Schimadzu gas chromatograph (model 17A; Schimadzu Corp., Palo Alto, CA) equipped 
with a Supelco SP-2560 capillary (100 m × 0.25 mm × 0.20 um; Supelco Inc., Bellefonte, 
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PA) using He as the carrier gas at a flow rate of 1.1 mL/min. Initial temperature was 
140°C for 4 min, and was increased by 4°C/min to a final temperature of 240°C.  
Experiment 3 
Heifers were arranged in a randomized complete block experiment with a 2 × 2 
factorial treatment arrangement to evaluate the effects of LSM and different management 
regimes on feedlot performance and carcass quality. Heifers (n = 366; initial BW = 374 ± 
0.6 kg) were housed in 48 concrete-surfaced pens (36 m
2
) containing 6 to 8 animals each. 
Pens provided overhead shade covering the fenceline bunk and half of each pen. Pens 
included automatic water fountains and 3.2 m of bunk space. Prior to this finishing trial, 
these heifers were in a growing trial consisting of three treatments. Heifers were blocked 
by the previous growing treatment and assigned randomly to 1 of 4 finishing diet 
treatments.  
Experimental treatments included diets based on dry rolled corn with or without 
solvent-extracted LSM, and management regimes with or without an estradiol/trenbolone 
acetate (ET) implant and melengestrol acetate (MGA). This resulted in four treatments, a 
conventional program consisting of Rev IH and MGA with no added LSM (Con Conv), 
Rev IH and MGA with LSM (LSM Conv), a non-hormone treated cattle (NHTC) 
program consisting of no implant or MGA with no added LSM (Con NHTC), and a 
NHTC program with LSM (LSM NHTC). Composition of diets is summarized in Table 
3.  
On d 1, heifers were weighed and implanted (Revalor IH, 80 mg of trenbolone 
acetate, 8 mg of estradiol; Intervet Inc., Millsboro, DE) according to treatment. Diets 
(Table 1) were formulated to be isocaloric and isonitrogenous and were fed once daily 
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such that animals had ad libitum access. Access to water was provided ad libitum with 
automatic water fountains. Weights of fresh feed were recorded daily. Feed refusals were 
recorded every 28 d or when in excess. These amounts on a DM basis were subtracted 
from the total feed offered to determine actual feed intake for each pen of cattle.  
Heifers were harvested across 2 d. Half of the weight blocks were harvested on d 
119 and the other on d 120. Final BW (gross BW × 0.96) was determined before cattle 
were transported to a commercial abattoir in Holcomb, KS. Incidence and severity of 
liver abscesses and HCW were recorded the d of harvest. Incidence and severity of liver 
abscesses were scored according to the scoring system (Brink et al., 1990): 0 = no 
abscesses, A
−
 = 1 or 2 small abscesses or abscess scars; A
0
 = 2 to 4 small, well-organized 
abscesses; and A
+
 = 1 or more large or active abscesses with or without adhesions. 
Carcass data were collected after a 48-h chill. Marbling scores, 12th rib fat thickness, LM 
area, KPH, USDA yield grades, and USDA quality grades were determined. Dressing 
percentage was calculated as HCW divided by shrunk BW. 
Dry matter intakes were calculated from the as-fed deliveries using actual 
feedstuff DM values, less the amount of unconsumed DM. Daily gain was calculated as 
kg of gain on a shrunk basis. Feed efficiency was calculated as kg of gain on a shrunk 
basis per kg of dry matter consumed.  
Statistical Analyses 
For all experiments, growth performance and carcass characteristics were 
analyzed using the MIXED procedure of SAS (version 9.0, SAS Inst. Inc., Cary, NC). 
Experimental unit was pen in experiments 1 and 3, and animal in experiment 2; diet and 
implant status served as fixed effects; and random effect was block in experiments 1 and 
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3, and animal in experiment 2. In experiments 1 and 3, USDA quality grade and liver 
abscesses were calculated and analyzed using the PROC GLIMMIX procedure of SAS 
(version 9.0, SAS Inst. Inc., Cary, NC). 
In experiment 2, USDA quality grade and liver abscesses were calculated and 
analyzed using Monte Carlo’s Chi Square analysis (Higgins, 2004) with animal as the 
experimental unit and the random effect. Ribs (n = 40; 10 per treatment) served as the 
experimental unit for muscle long-chain LCFA analyses. Plasma LCFA and muscle 
LCFA were analyzed using the MIXED procedure of SAS version 9.0, SAS Inst. Inc., 
Cary, NC). Animal was the experimental unit, diet and implant status were the fixed 
effects, and the random effect was animal for analysis of LCFA composition. The 
statistical analysis of plasma LCFA also included day, interactions between diet and day, 
and interaction between implant and day as fixed effects.  
Across all studies, mean comparisons were determined following an F-test with P 
≤ 0.05. Means and differences were considered different at P-value ≤ 0.05, and P-value 
of ≤ 0.10 was considered as a tendency.  
Results 
Experiment 1 
  
Performance and carcass quality results from experiment 1 are shown in Table 4. 
There was no effect (P ≥ 0.36) from interaction between diet and implant or diet on 
performance, contrary to the hypothesis that flaxseed lignans would promote growth 
naturally. But as expected, the ET implant improved rate of gain (P < 0.01), feed intake 
(P < 0.03), and feed efficiency (P < 0.01).  
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There were an interaction between diet and implant status that neared significance 
for a carcass trait. The interaction between diet and implant status tended to affect (P = 
0.08) KPH, so that control/implanted cattle had more KPH than flaxseed/implanted cattle, 
and control/no implant cattle had less KPH than flaxseed/no implant cattle. Diet affected 
some carcass traits. Feeding flaxseed decreased back fat thickness (P < 0.01) and USDA 
yield grade (P = 0.01) compared to cattle fed the control diet. Some carcass traits were 
affected by implant status. Carcass weights were improved (P < 0.01) when cattle were 
implanted, producing heavier carcasses by 9 kg or greater. Implanted cattle also produced 
more valuable carcasses, with increased LM area (P < 0.01) and decreased fat thickness 
(P = 0.02), resulting in lower USDA yield grade (P = 0.01).  
Experiment 2 
Performance and carcass characteristic results from experiment 2 are shown in 
Table 5. There was no effect (P ≥ 0.22) of diet or the interaction between diet and implant 
status on finishing performance, yet implants improved DMI (P = 0.02), ADG (P < 0.01) 
and feed efficiency (P < 0.01).  
Interactions between diet and implant status affected some carcass traits. The 
yield grades of the cattle fed flaxseed were greatly affected by the interaction of diet and 
implant status (P = 0.03), recording the extremes amongst treatments. When implanted, 
cattle fed flaxseed had the highest yield grade of all treatments, though this difference 
was only significant compared to flaxseed/no implant cattle. When cattle fed flaxseed 
were not implanted, they had the lowest yield grad of all treatments, though this 
difference was only significant compared to flaxseed/implant cattle. Why the yield grade 
of flaxseed changed greatly depending on implant status is not clear. A similar effect 
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from the interaction between diet and implant was observed for marbling scores (P = 
0.04). Cattle fed flaxseed reported the extremes of the marbling scores, depending on 
implant status. Flaxseed/no implant cattle had the lowest marbling scores of all 
treatments, but being significantly decreased only to soy oil/no implant and 
flaxseed/implant cattle. Flaxseed/implant cattle had one of the greatest marbling scores 
amongst treatments; however were only significantly increased compared to soy 
oil/implant and flaxseed/no implant cattle. Implant status affect few carcass traits. Hot 
carcass weights increased (P < 0.01) and dressing percentage decreased (P = 0.04) when 
cattle were implanted. There was no effect of diet (P ≥ 0.11) on carcass quality.  
 Results of fatty acid profiles are reported in Tables 6 and 7. With the exception of 
plasma C18:1n7, interactions between diet and implant status did not affect (P > 0.05) FA 
composition of plasma or LM tissues. Plasma total omega-3 increased (P < 0.01) when 
cattle were fed flaxseed. Subsequently, plasma n-6:n-3 fatty ratio also decreased (P < 
0.01) when cattle were fed flaxseed. Plasma SFA decreased (P < 0.01) when cattle were 
fed flaxseed. Many of the changes in plasma FA profiles were reflected in concentrations 
of LM FA. Longissimus muscle total omega-3 fatty acids increased (P < 0.01) with 
flaxseed feeding, subsequently decreasing (P < 0.01) n-6:n-3.  
Experiment 3 
Finishing performance was not affected (P ≥ 0.12) by the interaction between diet 
and exogenous hormones or the effect of diet, although exogenous hormones greatly 
affected performance. The use of anabolic steroids and estrous suppressants increased 
DMI (P = 0.02), ADG (P < 0.01), and improved feed efficiency (P < 0.01) in 
conventional cattle compared to NHTC. As in finishing performance, carcass quality was 
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not affected (P ≥ 0.10) by the interaction of diet and exogenous hormones or the effect of 
diet. Conventional cattle had increased HCW (P < 0.01), but greater KPH (P = 0.05) than 
NHTC.  
Discussion 
Performance 
Dunn et al. (2003) observed an interaction between ground flaxseed and implants 
(P < 0.05). Feeding LSM has been shown to interact with estradiol-17β in ovariectomized 
ewes, affecting estrogen-related jejunum growth and jejunum gene expression (O’Neil et 
al., 2009), and increasing liver weight and liver protein production with increased days 
fed LSM (O’Neil et al., 2006). From these results, we anticipated feeding flaxseed 
products to affect growth differently based on the exposure to exogenous hormones. In 
contrast, finishing performance results from the present three experiments indicate 
flaxseed products did not interact with the levels of exogenous hormones; however the 
interaction between diet and exogenous hormones neared tendency (P = 0.12) for ADG in 
experiment 3. Though the interaction effect was not significant for performance traits (P 
≥ 0.12), it is interesting to note numeric differences. The inclusion of exogenous 
hormones affected growth of cattle fed control diets more so than the growth of cattle fed 
flaxseed diets. This suggests feeding flaxseed products may replace some of the growth 
losses associated with the absence of exogenous hormones. Nevertheless, this effect is 
modest and only numeric. Feeding flaxseed products does not replace the growth effects 
of exogenous hormone entirely, but may promote modest growth improvements 
numerically. 
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There are differences in study designs between the previous and current 
experiments that may explain the differing results. O’Neil et al. (2006) and O’Neil et al. 
(2009) fed LSM and implanted exogenous hormones similar to experiment 3, but those 
authors studied the effects on digestive tissues of sheep rather than the effects on muscle 
tissues of cattle as in present study. Perhaps the different tissues and species altered the 
effect of flaxseed SDG between the studies.  
In experiments 1 and 2 feeding ground flaxseed did not affect (P ≥ 0.32) finishing 
performance, consistent with previous research. Concerning ground flaxseed, Maddock et 
al. (2006) and LaBrune et al. (2008) observed no effect on DMI, contrasting the findings 
of Drouillard et al. (2004), where ground flaxseed increased DMI. Studies feeding ground 
flaxseed at 5% diet DM (Drouillard et al., 2004) and 10% diet DM (LaBrune et al., 2008) 
also have reported no effect of flaxseed inclusion on ADG or G:F. In one instance ground 
flaxseed at an intermediate level of 8% diet DM has been shown to increase ADG and 
G:F (Maddock et al., 2006), but likely resulted from increased energy density in the 
flaxseed diet.  
Feeding LSM did not affect (P ≥ 0.25) finishing performance in experiment 3. 
Similarly, early studies have reported feeding LSM does not affect gain or efficiency 
when fed in confined beef systems (Matsushima et al., 1956; Webb et al., 1958) or 
grazing systems (Smith et al., 1958). Contrasting early studies and experiment 3, Kolari 
et al. (1960) combined data of 2 studies reporting that Hereford steers and heifers 
supplemented with LSM had 5% greater ADG compared to control cattle fed 
isonitrogenous diets, but reported no effects on DMI or feed efficiency. These early 
works demonstrate LSM supplementation generally does not affect performance in beef 
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systems. Recent dairy experiments show various levels of LSM supplementation does not 
affect (P > 0.05) DMI compared to isonitrogenous and isoenergetic control diets (Petit 
and Gagnon, 2009; Petit et al. 2009).  
Experiments 1 and 2 using ET implants, and experiment 3 using ET implants with 
MGA found exogenous hormones to increase DMI (P ≥ 0.02), ADG (P < 0.01), and feed 
efficiency (P < 0.01) when compared to cattle without exogenous hormones. This agrees 
with previous studies administering ET implants (Herschler et al. 1995) and ET implants 
with MGA (Kreikemeier and Mader, 2004).  
Carcass Quality 
Currently there are no known previous studies examining the effect of the 
interaction between flaxseed products and exogenous hormones on carcass 
characteristics. The interaction between diet and exogenous hormones affected KPH in 
experiment 1 (P = 0.08) and USDA yield grade in experiment 2 (P = 0.03), but exerted no 
effects (P ≥ 0.22) on carcass quality in experiment 3. Though these interaction effects 
were not consistent amongst the three experiments, it is interesting to note that the 
interaction affected carcass traits relating to fat. Fukumitsu et al. (2008) demonstrated the 
SDG of flaxseed to affect fat metabolism in diet-induce obese rats. Perhaps the 
interaction of exogenous hormones would influence the effect of flaxseed SDG on fat in 
ruminants.  
Feeding ground flaxseed decreased USDA yield grade (P = 0.01) and 12
th
 rib fat 
thickness (P = 0.01) in experiment 1, but did not affect (P ≥ 0.11) carcass quality in 
experiment 2. Similarly, previous studies have reported feeding ground flaxseed does not 
affect LM area, 12
th
 rib fat thickness, or incidence of liver abcesses (Maddock et al., 
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2006; LaBrune et al., 2008). As in experiments 1 and 2, LaBrune et al. (2008) reported 
HCW were not affected by ground flaxseed supplementation, but Maddock et al. (2006) 
had greater HCW in steers fed ground flaxseed than control steers.  
In experiment 3 feeding LSM did not affect (P ≥ 0.10) carcass characteristics, in 
agreement with results of Kolari et al. (1960). No other carcass characteristics were 
reported. The effects of LSM SDG on carcass traits have been studied more extensively 
in rat models. Flaxseed lignans have been shown to interact with estrogen receptors to 
promote skeletal muscle growth (Zhou et al., 2009) and decrease visceral fat in diet-
induced obese rats (Fukumitsu et al. 2008). Because of these findings, we anticipated 
similar responses with increased skeletal muscle measured as LM area and decreased 
visceral fat measured as KPH; however, carcass traits were not affected by diet in 
experiment 3. The lack of effect is possibly due to the differences in myogenesis and 
lipogenesis between rats and cattle. In agreement with an early beef study (Kolari et al. 
1960), but in contrast to recent rat experiments (Fukumitsu et al. 2008), feeding LSM did 
not affect LM area, KPH, or other carcass characteristics in experiment 3. The inclusion 
of flaxseed products affected few carcass traits and results were not consistent amongst 
the experiments. Overall, results suggest flaxseed products do not affect carcass quality.  
Exogenous hormones consistently increased (P < 0.01) HCW across all three 
experiments. This agrees with previous research studying the effects of ET implants 
(Herschler et al., 1995) and ET implants with MGA (Kreikemeier and Mader, 2004). In 
spite of consistent increases in HCW, other carcass traits were variably affected by 
exogenous hormones in the present studies. Both experiments 1 and 2 used implants with 
similar potency, yet only experiment 1 had increased LM area (P < 0.01), decreased 12
th
 
90 
rib fat thickness (P = 0.01), and lower USDA yield grade (P = 0.01); whereas only 
experiment 2 had decreased dressing percentage (P = 0.04). This contrasts the results of 
Herschler et al. (1995) where two experiments studying similar ET implants found HCW 
was the only carcass trait affected by implant status. The NHTC of experiment 3 had 
decreased HCW (P < 0.01) and KPH (P = 0.05) compared to conventionally managed 
cattle receiving ET implants and MGA. Similarly, Kreikemeier and Mader (2004) 
reported ET implants administered with MGA to increase HCW; however no other 
carcass traits were affected, including KPH. The increases in KPH and BF were not 
anticipated as earlier authors have reported no effect of implants and MGA on KPH or 
BF in heifers (Kreikemeier and Mader, 2000; Schneider et al., 2007); however, Wagner 
et al. (2007) reported that use of MGA increases carcass fatness regardless of implant 
type used. Though KPH and BF increased, these changes were not great enough to affect 
USDA yield grade (P = 0.91) in the present study. 
Feeding flaxseed increased (P < 0.01) α-linolenic acid and total omega-3 fatty 
acid, and decreased (P < 0.01) the n-6:n-3 fatty acid ratio in plasma and LM when cattle 
were fed flaxseed, agreeing with previous research (Drouillard et al. 2002; Drouillard et 
al., 2004; Good, 2004; Maddock et al., 2006; Kronberg et al., 2006; LaBrune et al., 
2008). Experiment 2 is the first study to report implants do interact (P > 0.05) with 
flaxseed to alter plasma or LM FA composition.  
The interaction between flaxseed products and exogenous hormones did not 
significantly affect finishing performance, though numeric differences were noted. 
Contrasting carcass results between experiments warrant further investigation of the 
interaction between flaxseed products and exogenous hormones. Feeding flaxseed may 
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be fed without negatively impacting performance or carcass quality. Using exogenous 
hormones like that found in conventional regimes improved DMI, ADG, feed efficiency, 
and HCW when compared to NHTC regimes. Contrary to the hypothesis, flaxseed SDG 
did not act as a natural growth promoter. However, ground flaxseed did increase 
desirable FA in saleable meat without compromising feedlot performance.  
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Table 1. Composition of experiment 1 diets reported on a DM basis.  
Item, % of DM Control Flaxseed 
Steam-flaked corn 74.25 69.72 
Ground alfalfa hay 8.00 8.00 
Fancy bleachable tallow 3.82 - 
Ground flaxseed - 10.00 
Corn steep liquor 7.50 7.50 
Soybean meal 1.19 0.23 
Urea 1.00 0.45 
Limestone 1.46 1.40 
Potassium chloride 0.15 0.07 
Salt 0.30 0.30 
Vitamin and mineral premix
a
 0.12 0.12 
Feed additive premix
b
 2.21 2.21 
Crude protein, % 14.00 14.00 
Crude fat, % 7.30 7.30 
a
Provided (DM basis) 2650 IU/kg vitamin A, 22 IU/kg vitamin E, 0.1 ppm Co, 10 ppm 
Cu, 0.5 ppm I, 60 ppm Mn, 0.25 ppm Se, 60 ppm Zn. 
b
Provided 300 mg monensin and 90 mg tylosin (Elanco Animal Health, Greenfield, IN) 
per hd/d. 
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Table 2. Composition of experiment 2 diets reported on a DM basis.
¥  
 
Item, % of DM Control Flaxseed  
Ingredients   
    Dry rolled corn 70.87 68.81 
    Corn silage 9.99 10.00 
    Ground flaxseed - 10.00 
    Corn steep liquor   3.00   3.00 
    Molasses 3.00   3.00 
    Soybean meal 4.05 - 
    RT premix 1.96 1.96 
    Limestone 1.67 1.64 
    Urea, 46% N 1.01 1.01 
    Salt 0.30 0.30 
    Vitamin premix 0.22 0.22 
    Trace mineral mix 0.06 0.06 
Nutrients, %   
    DM 73.19 74.60 
    CP 12.67 12.91 
    P   0.46   0.48 
    Ca   0.72   0.74 
    Ether extract   7.61 6.35 
    NDF 10.43 11.23 
¥
Formulated to provide provide 300 mg/d monensin, 90 mg/d tylosin (Elanco 
Animal Health, Greenfield, IN), 0.3% salt, 2650 IU vitamin A, 22 IU vitamin E, 
0.10 mg Co, 10 mg Cu, 0.5 mg I, 0.25 mg Se, 50 mg Mn, and 50 mg Zn per kg 
diet DM.  
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Table 3. Composition of experiment 3 diets on a DM basis.
¥
 
Item, % of DM Control Linseed Meal 
Ingredients   
    Dry rolled corn 54.3 49.7 
    Corn gluten 30.0 30.0 
    Corn silage 10.0 10.0 
    Linseed meal - 5.0 
    Feed additive
a
 2.16 2.16 
    Limestone 1.69 1.69 
    Potassium chloride 1.08 1.08 
    Urea, 46% N 0.36 0.36 
    Salt 0.30 0.30 
    Vitamin premix 0.06 0.06 
    Trace mineral mix 0.06 0.06 
Nutrients, %   
    DM 70.65 70.67 
    CP 14.04 14.20 
    P 0.48 0.51 
    Ca 0.58 0.55 
    Ether extract 3.59 3.42 
    NDF 24.20 25.01 
¥
Formulated to provide 0.3% salt; 2650 IU vitamin A; 22 IU vitamin E; 0.09 mg 
Co; 10 mg Cu; 0.5 mg I; 0.25 mg Se; 5 mg Mn; and 5 mg Zn per kg diet DM.  
a
Provided 300 mg monensin (Elanco Animal Health; Greenfield, IN), 90 mg 
tylosin, and 0 or 0.5 mg melengestrol acetate (Pfizer Animal Health; New York, 
NY) in a ground corn carrier. 
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Table 4. Experiment 1 effect of diet and implant status on performance and carcass characteristics.* 
 Control Flaxseed 
SEM 
P-values
§
 
Item Implant No Implant Implant No Implant Diet Implant DxI
¥
 
Initial BW, kg 396.0 397.8 394.2 396.0 4.4 0.68 0.65 0.97 
DMI, kg 8.98 8.68 8.70 8.42 0.15 0.59 0.03 0.60 
ADG, kg 1.65 1.39 1.66 1.34 0.05 0.64 <0.01 0.57 
G:F 0.186 0.163 0.192 0.162 0.008 0.55 <0.01 0.36 
HCW, kg 327.9 318.9 325.7 313.0 3.9 0.29 <0.01 0.68 
LM area, cm
2
 81.3 76.8 81.3 76.8 1.10 0.83 <0.01 0.93 
Fat thickness, cm 1.10 1.20 1.00 1.10 0.008 <0.01 0.02 0.88 
KPH, % 2.15 2.13 2.06 2.22 0.05 0.94 0.17 0.08 
Choice & prime, % 65.6 63.9 65.1 63.9 6.2 0.97 0.82 0.97 
Select, % 31.1 32.8 31.7 36.1 6.1 0.75 0.62 0.82 
Standard, % 3.3 1.6 3.1 0.0 1.8 0.63 0.18 0.67 
USDA yield grade 2.66 2.73 2.30 2.66 0.088 0.01 0.01 0.12 
*
Implant = cattle implanted with Revalor S (Intervet Inc., Millsboro, DE)
 
§
Effects of diet, implant status, interaction between diet and implant status P-values
 
protected by an overall F-test ≤ 0.05 
¥
DxI = interaction between diet and implant status
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Table 5. Experiment 2 effect of diet and implant status on performance and carcass characteristics.
†
 
 Control Flaxseed  P-value
§
 
Item Implant No Implant Implant No Implant SEM Diet Implant D×I
*
 
Initial BW, kg 498.2 498.5 497.7 496.9 15.2 0.69 0.94 0.83 
DMI, kg/d 12.63 11.62 12.53 12.50 0.54 0.32 0.02 0.22 
ADG, kg/d 1.16 0.83 1.12 0.90 0.09 0.87 <0.01 0.45 
G:F 0.091 0.071 0.088 0.071 0.005 0.81 <0.01 0.74 
HCW, kg 390 360 383 359 9.4 0.49 <0.01 0.60 
LM area, cm
2
 79.42 73.37 72.00 74.94 3.30 0.33 0.61 0.14 
Backfat, cm 0.54 0.46 0.45 0.47 0.06 0.53 0.60 0.40 
KPH, % 2.78 2.68 2.70 2.75 0.14 0.99 0.81 0.54 
Dressing percent 63.0 61.5 62.0 60.8 0.6 0.17 0.04 0.84 
USDA yield grade 2.63
ab
 2.80
ab
 3.00
a
 2.50
b
 0.15 0.79 0.26 0.03 
Marbling score
‡
 546
ab
 593
a
 563
a
 476
b
 38 0.11 0.52 0.04 
Select, %
¥
 0.0 0.0 0.0 10.0 - 1.00 1.00 1.00 
Choice, %
¥
 75.00 70.00 88.89 80.00 - 0.44 0.71 0.87 
Prime, %
¥
 25.00 30.00 11.11 10.00 - 0.24 1.00 0.66 
†
Implant = implanted with Revalor XS (Intervet Inc., Millsboro, DE) 
§ 
Effects
 
of diet, implant status, interaction between diet and implant status P-values
 
protected by an overall F-test ≤ 0.05 
*
D×I = interaction between diet and implant status 
‡
300 to 399 = Slight, 400 to 499 = Small, 500 to 599 = Modest, 600 to 699 = Moderate 
¥
Monte Carlo Exact Fit Chi Square Analysis (Higgins, 2004) 
a,b,c
Means within a row without common superscripts are different (P ≤ 0.05)
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Table 6. Experiment 2 effect of diet and implant status on plasma concentrations of fatty acids reported on an as-is basis.§ 
 d 0  d 28  d 56  d 84    
Fatty Acid, 
mg/L† 
Control Flaxseed  Control Flaxseed  Control Flaxseed  Control Flaxseed   
Imp No Imp Imp No Imp  Imp No Imp Imp No Imp  Imp No Imp Imp No Imp  Imp No Imp Imp No Imp SEM P-values* 
C12:0 1.73 1.76 3.21 2.11  1.31 1.75 2.13 2.30  1.80 2.16 1.43 1.03  1.22 2.45 1.67 2.60 0.66  
C14:0 2.39 1.85 1.30 0.84  2.27 1.62 1.89 1.45  1.92 5.80 3.85 3.86  1.40 1.29 2.52 1.40 0.96 T 
C14:1 2.35 1.74 2.54 3.31  2.28 3.93 1.64 2.48  2.74 2.31 3.34 5.29  1.80 2.70 2.36 4.92 0.93 I 
C16:0 153.6 140.7 134.4 148.8  162.7 154.9 131.3 130.4  139.4 143.5 132.5 132.6  140.0 129.2 117.5 123.5 7.87 D, T 
C16:1 21.07 23.75 20.48 23.49  12.64 11.02 19.32 20.75  4.16 11.58 13.70 17.50  3.43 2.30 2.53 5.50 2.33 D, T, X 
C17:0 10.03 5.58 10.56 7.94  4.71 5.23 5.54 3.00  1.98 2.60 1.24 1.72  3.07 9.44 9.16 7.68 1.76 T 
C17:1 5.43 5.56 5.89 4.31  3.64 5.27 2.68 1.91  3.29 3.16 2.45 1.82  3.50 4.13 3.64 2.40 0.90 D, T 
C18:0 235.6 238.6 218.5 234.9  295.6 271.7 242.2 218.8  241.6 245.2 240.2 227.2  248.0 217.2 195.6 220.3 16.2 D, T, X 
C18:n1t9 26.28 26.44 24.86 24.42  31.49 19.08 14.78 13.47  19.36 16.62 13.99 11.30  13.94 12.17 10.45 11.09 2.95 D, T 
C18:n1c9 96.98 93.91 85.01 87.75  86.83 81.19 88.89 84.96  84.71 85.38 96.35 86.80  68.90 68.69 83.59 78.76 6.39 T 
C18:1n7 12.98 10.23 9.79 12.01  13.53 7.71 8.97 9.90  9.87 6.55 6.96 5.45  4.92 2.58 2.68 3.22 1.78 T, W 
CLA c9, t11 3.16 2.75 0.95 0.87  2.05 1.33 0.98 0.72  0.89 1.69 2.58 1.15  2.25 2.26 1.86 1.53 0.63 D, X 
CLA t10, c12 3.14 1.73 1.73 2.26  0.90 1.18 1.84 2.49  0.90 1.10 0.93 1.54  1.38 1.68 0.64 0.50 0.71 T 
C18:2nt6 4.37 4.34 3.58 4.43  4.88 5.05 4.93 3.49  1.25 2.14 1.46 1.64  1.83 2.42 1.78 1.77 1.13 T 
C18:2nc6 595.4 579.3 579.9 584.7  906.1 823.9 654.9 693.9  745.3 743.2 692.7 660.5  703.2 641.5 604.8 649.6 47.5 D, T, X 
C18:3n3 24.00 20.04 13.77 24.15  27.97 42.68 135.12 133.27  18.66 22.05 168.73 151.26  15.53 14.68 129.54 150.30 9.22 D, T, X 
C18:3n6 19.77 16.08 21.62 22.87  13.57 21.33 11.32 13.21  20.45 16.01 10.63 11.31  11.52 14.33 8.83 8.84 2.90 T, X 
C20:0 2.76 1.25 1.91 1.62  2.54 2.62 1.42 1.46  1.73 1.33 2.47 2.02  2.56 2.46 1.96 2.06 0.64  
C20:1 2.55 1.43 2.42 2.90  1.43 2.22 1.37 1.31  1.39 0.89 1.47 1.62  1.05 1.18 2.59 3.08 0.68  
C20:2 7.47 5.12 5.47 5.60  2.33 3.23 2.41 4.40  2.91 3.14 4.17 5.67  3.36 3.81 4.32 2.98 0.87 T 
C20:3n6 42.94 41.03 38.59 36.05  31.29 31.76 18.72 24.26  33.87 37.14 15.02 16.77  26.88 26.89 18.25 14.48 3.40 D, T, X 
C20:4n6 0.99 0.53 0.25 1.09  0.40 0.53 0.74 1.91  0.19 1.09 0.99 0.88  0.96 2.52 3.26 0.83 0.60 T, Z 
C20:5n3 5.16 5.66 8.62 7.12  6.58 7.31 12.74 12.72  4.77 4.37 12.64 12.59  5.24 7.65 12.14 16.52 1.48 D, T, X 
C21:0 3.37 2.58 1.63 1.73  1.88 0.40 0.55 0.69  1.57 2.49 1.36 2.24  1.22 1.38 1.45 0.75 0.63 T 
C22:0 3.71 3.96 2.68 2.48  2.07 1.32 1.55 2.21  2.30 1.82 2.88 1.95  2.69 3.45 1.45 1.13 0.78  
C22:5n3 2.95 2.69 2.12 3.95  3.66 2.63 1.23 1.81  1.22 2.53 2.27 2.36  3.33 2.71 4.22 3.01 0.81  
C22:6n3 6.50 5.32 6.22 5.81  3.72 3.86 4.05 4.89  4.18 2.18 2.81 1.73  2.00 2.00 3.24 2.49 0.92 T 
C24:0 1.46 3.70 3.91 3.12  3.01 2.43 1.76 4.41  2.05 2.44 1.69 2.26  1.72 4.22 1.95 3.12 0.89 I 
C24:1 2.49 1.48 1.63 3.20  1.72 1.79 1.46 1.77  1.35 1.19 1.03 1.86  2.03 2.72 2.38 1.46 0.66  
Total 1293 1241 1208 1258  1630 1513 1372 1393  1347 1360 1431 1362  1270 1180 1228 1318 78 T, X 
§Imp = implanted with Revalor XS (Intervet Inc., Millsboro, DE); No Imp = not implanted. 
*Denotes significance at P < 0.05. Effects represented as D = diet; I = implant status; T = sample day; W = two-way interaction between diet and implant status; X = two-way interaction between diet and sample day; Y = two-way interaction between 
implant status and sample day; Z = three-way interaction between diet, sampling day and implant status.  
a,b,cMeans within a row without common superscripts are different (P ≤ 0.05). 
†Number after C denotes number of Carbons; n denotes the double bond location from the omega position; c and t denote the cis or trans configuration. 
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Table 7. Experiment 2 effect of diet and implant status on longissimus muscle concentrations of fatty acids 
reported on an as-is basis.
†
  
Fatty acid, 
mg/kg¥ 
Control Flaxseed  P-value§ 
Implant No Implant Implant No Implant SEM Diet Implant D×I‡ 
C14:0 0.271 0.291 0.224 0.219 0.031 0.05 0.81 0.67 
C14:1 0.046 0.048 0.040 0.045 0.013 0.70 0.78 0.89 
C16:0 2.04 2.27 1.84 1.84 0.19 0.09 0.54 0.52 
C16:1 0.323 0.258 0.266 0.273 0.038 0.56 0.43 0.32 
C17:0 0.093 0.086 0.096 0.095 0.006 0.29 0.53 0.60 
C17:1 0.068 0.076 0.064 0.070 0.008 0.55 0.36 0.85 
C18:0 1.11 1.34 1.11 1.12 0.110 0.29 0.26 0.28 
C18:n1t9 0.269 0.313 0.181 0.200 0.027 <0.01 0.22 0.62 
C18:n1c9 2.77 3.26 2.69 2.86 0.27 0.36 0.20 0.53 
C18:1n7 0.135 0.167 0.130 0.142 0.014 0.26 0.10 0.45 
CLA c9, t11 0.0034 0.0026 0.0003 0.0016 0.0007 <0.01 0.72 0.15 
CLA t10, c12 0.0006 0.0008 0.0002 0.0009 0.0005 0.73 0.33 0.56 
C18:2nt6 0.014 0.015 0.026 0.026 0.002 <0.01 0.71 0.86 
C18:2nc6 0.335 0.340 0.278 0.300 0.025 0.04 0.56 0.71 
C18:3n3 0.015 0.017 0.073 0.077 0.005 <0.01 0.61 0.84 
C18:3n6 0.003 0.004 0.003 0.003 0.001 0.39 0.40 0.55 
C20:0 0.005 0.006 0.009 0.010 0.001 <0.01 0.15 0.83 
C20:1 0.018 0.018 0.016 0.018 0.002 0.48 0.51 0.65 
C20:2 0.006 0.006 0.005 0.007 0.001 0.70 0.40 0.40 
C20:3n6 0.012 0.015 0.011 0.008 0.002 0.07 0.87 0.12 
C20:4n6 0.001 0.001 0.003 0.003 0.0003 <0.01 0.70 0.24 
C20:5n3 0.002 0.002 0.003 0.003 0.0008 0.16 0.34 0.86 
C21:0 0.021 0.021 0.014 0.019 0.004 0.22 0.52 0.59 
C22:0 0.003 0.003 0.004 0.004 0.001 0.38 0.97 0.99 
C22:5n3 0.003 0.002 0.002 0.002 0.0006 0.21 0.57 0.12 
C22:6n3 0.003 0.005 0.006 0.006 0.002 0.29 0.73 0.60 
C24:0 0.0030 0.0015 0.0026 0.0021 0.0003 0.79 <0.01 0.08 
C24:1 0.0009 0.0011 0.0011 0.0011 0.0004 0.73 0.75 0.73 
Total 7.58 8.58 7.11 7.36 0.67 0.19 0.33 0.55 
omega-3d 0.023 0.026 0.084 0.089 0.006 <0.01 0.49 0.84 
omega-6e 0.371 0.378 0.319 0.342 0.026 0.05 0.47 0.72 
n-6:n-3f 17.69 16.80 3.97 3.93 1.50 <0.01 0.74 0.76 
SFAg 3.55 4.02 3.30 3.30 0.33 0.13 0.45 0.44 
MUFAh 3.62 4.14 3.39 3.61 0.33 0.23 0.24 0.64 
PUFAi 0.398 0.411 0.409 0.438 0.032 0.52 0.50 0.79 
†Imp = implanted with Revalor XS (Intervet Inc., Millsboro, DE); No Imp = not implanted. 
§ Effect of diet P-value protected by an overall F-test ≤ 0.05. 
¥Number after C = number of Carbons; n = double bond location from the omega position; c and t = the cis or trans 
configuration.  
‡D×I = interaction between diet and implant. 
a,b,cMeans within a row without common superscripts are different (P ≤ 0.05). 
domega-3 = C18:3n3 + C20:5n3 + C22:5n3 + C22:6n3 
eomega-6 = C18:2nt6 + C18:2nc6 + CLAc9t11 + CLAt10c12 + C18:3n6 + C20:3n6 + C20:4n6  
fn-6:n-3 = omega-6 / omega-3 
gSFA = C14:0 + C16:0 + C17:0 + C18:0 + C20:0 + C21:0 + C22:0 + C24:0 
hMUFA = C14:1 + C16:1 + C17:1 + C18:1nt9 + C18:1n11 + C18:1nc9 + C18:1n7 + C20:1 + C24:1 
iPUFA = C18:2n6t + C18:2n6c + CLAc9t11 + CLAt10c12 + C18:3n6 + C18:3n3 + C20:2 + C20:3n6 + C20:4n6 + C20:5n3 + 
C22:5n3 + C22:6n3 
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Table 8. Experiment 3 effects of diet and feeding regime on performance and carcass characteristics.* 
 Control Linseed meal 
SEM 
P-values
§
 
Item Conventional NHTC Conventional NHTC Diet Regime D×R
¥
 
Initial BW, kg 372.5 376.7 370.9 376.5 4.4 0.84 0.27 0.87 
DMI, kg 9.99 9.55 10.05 9.83 0.15 0.25 0.02 0.45 
ADG, kg 1.29 1.09 1.23 1.12 0.03 0.66 <0.01 0.12 
G:F 0.129 0.114 0.123 0.114 0.002 0.20 <0.01 0.24 
HCW, kg 323.8 311.2 321.9 314.0 3.4 0.89 <0.01 0.49 
LM area, cm
2
 81.3 79.4 82.0 80.2 1.13 0.53 0.11 0.95 
Fat thickness, cm 1.64 1.49 1.61 1.52 0.06 0.98 0.04 0.67 
KPH, % 2.36 2.32 2.44 2.31 0.04 0.36 0.05 0.33 
Dressing percent 61.51 61.42 62.09 61.56 0.002 0.10 0.16 0.30 
Average YG 2.78 2.63 2.65 2.78 0.11 0.94 0.91 0.22 
Liver abcesses, % 15.76 16.00 13.05 16.52 3.86 0.77 0.62 0.67 
Marbling score
‡
 474 488 482 483 9.87 0.85 0.42 0.52 
Select, % 17.86 15.08 16.52 16.30 4.00 0.99 0.74 0.70 
Choice, % 77.90 75.77 77.28 76.92 4.54 0.95 0.78 0.84 
Prime, % 4.24 9.15 6.56 6.42 2.65 0.94 0.33 0.36 
*
NHTC = non-hormone treated cattle, Conventional = implanted with Revalor IH (Intervet Inc., Millsboro, DE) and fed melengestrol 
acetate (Pfizer Animal Health; New York, NY).  
§
Effects
 
of diet, management regime, and the interaction between diet and management regime P-values
 
protected by an overall F-test ≤ 
0.05 
¥
D×R represents the interaction between diet and management regime 
‡
300 to 399 = Slight, 400 to 499 = Small, 500 to 599 = Modest, 600 to 699 = Moderate 
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 SEM = 9.64    Diet×implant×DOF, P = 0.17    Diet×implant, P = 0.97    Diet×DOF, P < 0.01     
Implant×DOF, P = 0.36    Diet, P < 0.01    Implant, P = 0.58    DOF, P < 0.01 
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SEM = 1.7    Diet×implant×DOF, P = 0.25    Diet×implant, P = 0.64    Diet×DOF, P < 0.01    
Implant×DOF, P = 0.93    Diet, P < 0.01    Implant, P = 0.10    DOF, P < 0.01 
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SEM = 10.0    Diet×implant×DOF, P = 0.71    Diet×implant, P = 0.56    Diet×DOF, P = 0.23     
Implant×DOF, P = 0.74    Diet, P = 0.83    Implant, P = 0.52    DOF, P < 0.01 
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SEM = 54.8    Diet×implant×DOF, P = 0.38    Diet×implant, P = 0.52    Diet×DOF, P < 0.01    
Implant×DOF, P = 0.97    Diet, P = 0.92    Implant, P = 0.85    DOF, P < 0.01 
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SEM = 23.2    Diet×implant×DOF, P = 0.42    Diet×implant, P = 0.49    Diet×DOF, P = 0.06    
Implant×DOF, P = 0.58    Diet, P = 0.01    Implant, P = 0.70    DOF, P < 0.01   
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Figure 1. Effect of diet, implant, day, and the interactions between the factors on plasma 
concentrations of fatty acids reported on an as-is basis. 
Control Implant ▬♦▬; Control No Implant ▬ ■ ▬; Flaxseed Implant - ▲ -; Flaxseed 
No Implant ▬×▬ 
A. Effect of Diet and Day on Plasma Concentrations of Omega-3 Fatty Acids 
B. Effect of Diet and Day on Plasma n-6:n-3 Fatty Acid Ratio 
C. Effect of Diet and Day on Plasma Concentrations of Monounsaturated Fatty Acids 
D. Effect of Diet and Day on Plasma Concentrations of Polyunsaturated Fatty Acids 
E. Effect of Diet and Day on Plasma Concentrations of Saturated Fatty Acids 
